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Locking the spatial orientation of a molecule's substituents is 
essential in order to induce desirable properties such as bioactivity 
or supramolecular organization. Nitrogen-substituted cyclobutanes 
in particular combine a small and rigid carbocyclic skeleton with  
amine-based functional groups which are omnipresent in bioactive 
compounds.[1] In fact, this scaffold can be found in natural or 
synthetic biologically active compounds such as Lannotinidine F (1), 
Cyclobut-G (2) or rhodopeptin analog 3 (Figure 1).[2] The use of 
aminocyclobutanes as constrained amino acids has been also studied 
as their introduction into peptides results in foldamers with 
interesting properties ranging from cell-penetrating agents to low-
molecular-weight gelators.[3]  
Figure 1. Examples of aminocyclobutanes in natural products and 
synthetic bioactive compounds. 
In addition to their exceptional structural properties, 
cyclobutanes are also versatile synthetic precursors.[4] Nevertheless, 
the use of  donor-acceptor-substituted cyclobutanes to access formal 
1,4-dipoles has been far less exploited than for cyclopropanes in the 
case of formal 1,3-dipoles.[5] The first report of such a process was 
described by Saigo in 1991 in a formal [4 + 2] cycloaddition 
between aminocyclobutanes and carbonyls.[5a]  However, the 
nitrogen atom was lost during the process. All further effort and 
success were later reported using carbo- and alkoxy- substituted 
four-membered rings. [5b-f] 
The structural and synthetic versatility of aminocyclobutanes 
makes the development of new methods towards their synthesis 
particularly attractive. In the past, photochemical and thermal [2+2] 
cycloadditions have been most often applied to the synthesis of 
cyclobutanes.[6-8] However, the scope of these transformations was 
limited, and often harsh conditions or specialized equipment was 
required. An alternative strategy based on organocatalysis was 
recently reported, but it remains limited to the specific case of 
nitrocyclobutanes.[9] Methods  involving Lewis acid catalysts were 
successful for diverse donor-acceptor-substituted cyclobutanes.[10,11] 
In the specific case of aminocyclobutanes however, there is only a 
single report by Avenoza and co-workers, who made use of a 
superstoichiometric amount of an aluminum Lewis acid for the 
synthesis of α-amino acid derivatives (Scheme 1, (a)).[12] There is 
consequently a great need for milder catalytic methods giving access 
to differently substituted aminocyclobutanes.  
Herein, we report the first Lewis acid-catalyzed [2+2] 
cycloaddition between enimides and alkylidene malonates to access 
-amino acid cyclobutane derivatives (Scheme 1, (b)). The reaction 
involves the use of cheap and non-toxic iron trichloride as catalyst 
and tolerates a wide range of substituents. The method can be used 
to afford the aminocyclobutanes in gram quantities and the synthetic 
potential of the obtained products was demonstrated by their 
transformation into a -peptide derivative and the first example of 
catalytic [4+2] cycloaddition of aminocyclobutane proceeding 
without loss of the precious nitrogen atom.  
 
Scheme 1. Lewis Acid-mediated [2+2] cycloaddition for the synthesis 
of aminocyclobutanes. MAO: methylaluminoxane, MABR: 
methylaluminum bis(4-bromo-2,6-di-tert-butyl phenoxide). 
We recently reported that di(alkoxycarbonyl)-substituted 
cyclopropanes were stable yet still reactive as formal dipoles when 
substituted by a phthalimide.[13] We wondered if a similar strategy 
could be also applied in the case of aminocyclobutanes. 
Consequently, commercially available N-vinyl phthalimide (4a) and 
methylidene malonate 5a were chosen as partners to attempt the 
synthesis of aminocyclobutane 6aa (Table 1). The use of the 
conditions reported for the synthesis of carbo- or alkoxy-substituted 
cyclobutanes[5] was not successful in this case (entries 1-3). 
Nevertheless, when using scandium triflate as catalyst, some traces 
of product could be detected by 1H NMR (entry 3) and by increasing 
the reaction temperature a complete conversion could be obtained 
(entries 4 and 5). In this case, the major product was the desired 
cyclobutane 6aa. At higher temperature than 0 °C, degradation of 
vinylphthalimide (4a) as well as product 6aa was observed. In order 
to test this system with less reactive substrates, commercially 
available ethylidene malonate 5b was used in the presence of 
scandium triflate at room temperature (entry 6). As no conversion 
was observed in this case, other Lewis acids were examined for the 
[2+2] cycloaddition. Indium triflate and iron trichloride supported 
on alumina[14] were able to catalyze the reaction even if full 
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conversion was not reached for indium (entries 7 and 8).[15] Based 
on these preliminary results, the iron catalyst was selected for the 
study of the scope of the reaction.  
Table 1. Optimization of the [2+2] cycloaddition. 
 
Entry Catalyst (mol %) t (h) Malonate T (°C) Ratio 6/4[a] 
1 ZnBr2 (100)
[b] 1 5a -78 0:1 
2 Yb(OTf)3 (10)
[b] 0.75 5a -78 0:1 
3 Sc(OTf)3 (10)
[b] 0.75 5a -78 Traces of 6 
4 Sc(OTf)3 (10)
[b] 0.75 5a -30 1:2 
5 Sc(OTf)3 (10)
[b] 0.5 5a 0 1:0 
6 Sc(OTf)3 (20)
[c] 12 5b rt 0:1 
7 In(OTf)3 (20)
[c] 12 5b rt 1.5:1 
8 FeCl3•Al2O3 (20)
[c] 12 5b rt 1:0 
  [a] Monitored by 1H NMR. Reaction conditions: See supporting 
information for details. [b] Following reported procedures.[5] [c] Lewis 
acid (0.2 eq), dimethyl 2-ethylidenemalonate (5b) (1 eq) and 2-
vinylisoindoline-1,3-dione (4a) (1.2 eq) added dropwise, 
dichloromethane, 0.1 mM. Phth = Phthaloyl. 
On preparative scale using 10 mol % of catalyst, iron trichloride 
on alumina was also a good catalyst for the reaction between 
vinylphthalimide (4a) and unsubstituted methylidene malonate 5a 
(Scheme 2). Variation of the nitrogen substituent was first 
examined.[16] Succinimide as well as maleimide were tolerated, 
giving the cyclobutanes 6ba and 6ca in 91% and 48% yield 
respectively. The reaction also allowed the formation of Boc 
protected thymine cyclobutane 6da in 76% yield. The use of a N-
vinyl-oxazolidinone failed to deliver product 6ea due to 
decomposition of the starting material. Cycloaddition of keto ester 
substrates was possible, affording cyclobutane 6ac in 62% yield. 
At this point, we turned to the synthesis of multi-substituted 
aminocyclobutanes. The use of (E)-enimides,[17] was examined first. 
Enimides substituted with a methyl, a hexyl or a cyclopropyl group 
afforded the corresponding cyclobutanes 6fa, 6ga and 6ha in 74-
85% yield. An aliphatic chloro substituent was also compatible with 
the reaction conditions (product 6ia). Succinimide substituted 
cyclobutanes could also be obtained in 81-83% yield (products 6ja 
and 6ka). Importantly, in all the experiments involving (E)-enimides 
except for the formation of cyclobutane 6ka, only one cyclobutane 
diastereoisomer could be detected in the crude mixture of the 
reaction. Aromatic substitution of the enimide was next investigated. 
The reaction delivered a single diastereoisomer of cyclobutane 6la 
bearing a phenyl substituent in 90% yield. Adding a para-bromo 
substituent on the benzene ring slowed down the reaction and no full 
conversion to cyclobutane 6ma was observed. However, decreasing 
the conjugation of the benzene ring with the enimide by moving the 
bromine atom to the ortho position[18] restored the reactivity and 
product 6na could be obtained in 93% yield. Finally, in the presence 
of a trifluoromethyl group, the reaction was slower, but cyclobutane 
6oa could still be obtained in 38% yield (45% based on recovered 
starting material).  
Scheme 2. Scope of the [2+2] cycloaddition with methylidene 
dicarbonyl compounds. E = CO2Me. Succ = Succinyl. Reaction 
conditions: Enimide (0.20 mmol, 1 eq), alkylidene malonate (0.40 
mmol, 2 eq), Fe catalyst (1 mmol/g, 20 mg, 0.020 mmol, 0.1 eq) in 
CH2Cl2 (1 mL) for 0.2-5 h. [a] E = CO2Et. [b] 4 equivalents of 
methylidene malonate were used. [c] Based on recovered starting 
material, 50% isolated yield. [d] Based on recovered starting 
material, 38% isolated yield. 
When we switched to electron-rich aromatic rings as 
substituents, we observed a different regioselectivity (Scheme 3). 
When tolyl-substituted enimide 4p was used, a 2.5:1 mixture of 
"normal" and "inverted" products 6pa and 6pa’ was obtained (1). p-
Methoxy benzene-substituted substrate 4q gave only the "inverted" 
product 6qa’ (2). This switch in regioselectivity is interesting as it 
gives access to equally important -amino acid cyclobutane 
derivatives.[19] Additionally, it allowed assigning the relative 
donating ability of the phthaloyl compared to electron rich aromatic 
groups in the [2+2] cycloaddition, which may be also useful in the 
future for the design of other transformations. 
 
Scheme 3. [2+2] Cycloaddition with enamides substituted with 
electron-rich benzene rings. Tol = tolyl. 
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Less reactive substituted alkylidene malonates[20]  also afforded 
cyclobutanes 6ab-e in 59-71% yields, but usually without 
diastereoselectivity when using methyl ester substrates (Scheme 
4).[21] The use of benzyl substituted alkylidene malonates 5f allowed 
the formation of the product 6af in a better 3:1 diastereomeric ratio 
and 62% yield. In the case of trifluoromethyl-substituted 
aminocyclobutane 6ag only the trans-diastereoisomer was obtained 
in 76% yield. This is an important result, as methods for the 
synthesis of trifluoromethyl substituted aminocyclobutanes are rare, 
require numerous steps and usually lack diastereoselectivity.[6b, 22] 
 
Scheme 4. Scope of the [2+2] cycloaddition with alkylidene 
malonates. Reaction conditions: Enimide (0.20 mmol, 1 eq), 
alkylidene malonate (0.40 mmol, 2 eq), Fe catalyst (1 mmol/g, 20 mg, 
0.020 mmol, 0.1 eq) in CH2Cl2 (1 mL). Cy = cyclohexyl. 
Methylidene malonates such as 5a are very reactive species and 
start to decompose after a few days even when stored under argon at 
-20 °C. The access to this building block involves a complex 
Knoevenagel/Diels-Alder/recrystallization/cracking sequence 
followed by a base sensitive distillation in paraffin.[23] This difficult 
access to the methylidene malonates was a serious limitation for the 
preparative use of our [2+2] cycloaddition methodology. We found 
that the protocol developed by Connell and co-workers for the 
methenylation of dicarbonyl compounds[24] could be adapted to the 
synthesis of the sensitive methylidene malonates (Scheme 5). When 
the reaction was completed, the crude mixture could be used directly 
into the cycloaddition reaction. The efficacy of this protocol was 
demonstrated by accessing cyclobutanes 6aa, 6ah, 6ai and 6fa 
within a few hours from commercially available starting materials 
on a gram scale using 5 mol % catalyst loading. 
 
Scheme 5. Gram-scale synthesis of aminocyclobutanes. 
In order to better understand the reaction mechanism, it would 
be important to know if the reaction is stereospecific in relation to 
the geometry of the enamide or if the observed high trans-
diastereoselectivity is due only to thermodynamic control. When 
using (Z)-substituted enimides, no conversion was detected, even 
after prolonged reaction times. The lack of reactivity in the case of 
the (Z) isomer could be tentatively attributed to the loss of 
conjugation between the nitrogen p orbital and the  system of the 
olefin due to steric interactions, leading to lower nucleophilicity. To 
answer the question of stereospecificity, deuterated enimide 4r was 
consequently synthesized[25] and submitted to the reaction 
conditions (Scheme 6). Only a slight loss of stereoinformation was 
observed during the reaction. This result supported a stepwise 
mechanism via a zwitterionic intermediate I, but also indicated a 
fast ring-closure, which could compete with single bond rotation.  
 
Scheme 6. Reaction with deuterated enamide 4r and speculative 
zwitterionic intermediate I.  
We finally selected two key transformations to highlight the 
potential of aminocyclobutanes both as synthetic precursors and as 
structural units (Scheme 7). First, the tin tetrachloride-catalyzed 
reaction of aminocyclobutane 6aa with enol silane 9 afforded one 
diastereoisomer of aminocyclohexane 10 in 95% yield (1). This is to 
the best of our knowledge the first report of such a formal [4+2] 
cycloaddition[26] between an aminocyclobutane and an olefin. 
Second, conversion of cyclobutane 6ag to glycine-dipeptide 11 was 
achieved in three steps with an overall yield of 78% (2).[27]  
 
Scheme 7. [4+2] Formal cycloaddition and synthesis of dipeptide 11. 
In conclusion, we have developed the first Lewis acid-catalyzed 
[2+2] cycloaddition for the synthesis of -amino acid cyclobutane 
derivatives. The reaction gave access to multi-substituted 
cyclobutanes, including important derivatives for medicinal 
chemistry, such as nucleoside analogues or trifluoromethylated 
compounds. A simplified access to highly sensitive methylidene 
malonates was developed, allowing the gram scale synthesis of 
aminocyclobutanes. The synthetic potential of the obtained 
aminocyclobutanes was demonstrated by their transformation into a 
-peptide derivative and by the first example of catalytic [4+2] 
annulation reaction for the synthesis of cyclohexylamines. 
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General remarks 
All reactions were carried out in oven-dried glassware under an atmosphere of nitrogen, unless stated 
otherwise. For quantitative flash chromatography, technical grade solvents were used. For flash 
chromatography, for analysis, HPLC grade solvents were used. THF, Et2O, toluene, hexane and 
CH2Cl2 were dried by passage over activated alumina under nitrogen atmosphere (H2O content < 7 
ppm, Karl-Fischer titration). All chemicals were purchased and used as received unless stated 
otherwise. Chromatographic purification was performed as flash chromatography using Macherey-
Nagel silica 40-63, 60 Å, using the solvents indicated as eluent with 0.1-0.5 bar pressure. TLC was 
performed on Merck silica gel 60 F254 TLC plastic plates and visualized with UV light, CAN or p-
anisaldehyde stains. Melting points were measured on a calibrated Büchi B-540 melting point 
apparatus using open glass capillaries. 1H-NMR spectra were recorded on a Brucker DPX-400 400 
MHz spectrometer in chloroform-d, all signals are reported in ppm with the internal chloroform signal 
at 7.26 ppm as standard. The data is being reported as (s = singlet, d = doublet, t = triplet, q = 
quadruplet, qi = quintet, m = multiplet or unresolved, br = broad signal, integration, coupling 
constant(s) in Hz, interpretation). 13C-NMR spectra were recorded with 1H-decoupling on a Brucker 
DPX-400 100 MHz spectrometer in chloroform-d, all signals are reported in ppm with the internal 
chloroform signal at 77.16 ppm as standard. Infrared spectra were recorded on a JASCO FT-IR B4100 
spectrophotometer with an ATR PRO410-S and a ZnSe prism and are reported as cm-1 (w = weak, m 
= medium, s = strong). High resolution mass spectrometric measurements were performed by the mass 
spectrometry service of ISIC at the EPFL on a MICROMASS (ESI) Q-TOF Ultima API. Iron-
Alumina complex was synthesized following the procedure of Tietze.1 Diatereomeric mixtures have 
been assigned by 2D NMR experiments including COSY/ROESY/HSQC/HMBC. COmmercialy 
available N-Vinyl Phthalimide [3485-84-5], N-Vinyl-2-pyrrolidone [88-12-0] and Diethyl 
Ethylidenemalonate [1462-12-0] were used. 
  
                                                          
1 Organic Syntheses, Vol. 71, p. 167 (1993); Coll. Vol. 9, p.310 (1998). 
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1. Synthesis of enimides 
1-Vinylpyrrolidine-2,5-dione (4b) 
 
Following a modified procedure,2 to a stirred solution of pyrrolidine-2,5-dione (12) (1.00 g, 10.1 
mmol, 1.00 eq) in vinyl acetate (25.0 mL, 270 mmol, 26.8 eq) was added Na2PdCl4 (59.0 mg, 0.202 
mmol, 0.02 eq). The mixture was heated under reflux for 72 h. The crude was purified by Biotage 
(SNAP Cartridge KP-Sil 50 g, 7:3 Hexane/AcOEt) to obtain 1-vinylpyrrolidine-2,5-dione (4b) as a 
yellow solid (1.22 g, 9.78 mmol, 97 % yield). 
Rf 0.17 (Hexane/Ethyl acetate 8/2). 
Mp 47.6-48.9 °C. 
1H NMR (400 MHz, CDCl3) δ 6.68 (dd, 1 H, J = 16.4, 9.9 Hz, =CH), 6.08 (d, 1 H, J = 16.4 Hz, =CH), 
5.06 (d, 1 H, J = 9.9 Hz, =CH), 2.72 (s, 4 H, CH2). 
13C NMR (101 MHz, CDCl3) δ 175.4, 124.3, 106.6, 27.8.  
IR 2946 (w), 1707 (s), 1382 (s), 1307 (m), 1222 (s), 1113 (s), 974 (m), 906 (m), 821 (w). 
HRMS (ESI) calcd for C6H7NO2+ [M+H]+ 126.0555; found 126.0549. 
1-Vinyl-1H-pyrrole-2,5-dione (4c) 
 
1H-Pyrrole-2,5-dione (13) (1.30 g, 13.4 mmol, 1 eq), palladium(II) chloride (237 mg, 1.34 mmol, 0.1 
eq), lithium chloride (57.0 mg, 1.34 mmol, 0.1 eq) and vinyl acetate (33.2 mL, 359 mmol) were added 
in a sealed tube under nitrogen. The mixture was heated at 80 °C for 23 h. The reaction was diluted 
with dichloromethane and 20 g of silica were added. The crude was concentrated under reduced 
pressure, and purified by Biotage (SNAP Cartridge KP-Sil 50 g, 7:3 Hexane/AcOEt) to afford 1-vinyl-
1H-pyrrole-2,5-dione (4c) (1.74 g, 14.1 mmol, 100 % yield) as a yellow oil. 
Rf 0.54 (Hexane/Ethyl acetate 7/3).  
MP 66.2-69.7 °C. 
1H NMR (400 MHz, CDCl3) δ 6.74 (s, 2 H, CH-C=O), 6.67 (dd, 1 H, J = 16.4, 9.8 Hz, CH-N), 5.87 
(d, 1 H, J = 16.3 Hz, =CH2), 4.94 (d, 1 H, J = 9.8 Hz, =CH2). 
13C NMR (101 MHz, CDCl3) δ 168.7, 134.5, 123.1, 103.4. 
IR 3087 (w), 1716 (s), 1641 (w), 1415 (m), 1384 (s). 
HRMS (APPI) calcd for C6H5NO2+ [M+] 123.0320; found 123.0323. 
tert-Butyl 5-methyl-2,6-dioxo-3-vinyl-2,3-dihydropyrimidine-1(6H)-carboxylate (4d) 
                                                          
2 Baret, N.; Dulcere, J.-P.; Rodriguez, J.; Pons, J.-M.; Faure, R. Eur. J. Org. Chem. 2000, 2000, 1507. 
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In a sealed vial were added palladium acetate (36.0 mg, 0.160 mmol, 0.04 eq), vinyl acetate (881 µl, 
9.52 mmol, 2.4 eq), 5-methylpyrimidine-2,4(1H,3H)-dione (14) (500 mg, 3.96 mmol, 1eq), TMSOTf 
(1.72 mL, 9.52 mmol, 2.4 eq) and DMF (10.0 mL). The reaction was stirred for 16 hours at 70 °C, 
then water (25 mL) was added. The reaction was extracted three times with ethyl acetate (30 mL). 
Then, the organic layers were combined and washed three times with water (30 mL). The organic 
layer was dried over magnesium sulfate and concentrated under reduced pressure. The crude product 
was purified by column chromatography, eluting with hexane/ethyl acetate/NEt3 (7/3/0.01) to obtain 
5-methyl-1-vinylpyrimidine-2,4(1H,3H)-dione (15) (269 mg, 1.77 mmol, 45% yield) as a colorless 
solid. 
Rf 0.5 (Hexane/Ethyl acetate 1/1). 
Mp 208.0-209.1°C.  
1H NMR (400 MHz, CDCl3) δ 9.17 (s, 1 H, NH), 7.34 (s, 1 H, C=C-H), 7.21 (dd, 1 H, J = 16.0, 9.1 
Hz, -CH=C vinyl), 5.07 (dd, 1 H, J = 16.0, 2.1 Hz, C=CH2 vinyl, trans), 4.91 (dd, 1 H,J = 9.1, 2.1 Hz, 
C=CH2 vinyl, cis), 1.99 (s, 3 H, Me).  
13C NMR (101 MHz, CDCl3) δ 163.6, 149.3, 134.5, 129.6, 112.1, 100.5, 12.6. 
IR 3180 (w), 3062 (w), 2827 (w), 1645 (s). 
HRMS (ESI) calcd for C7H9N2O2+ [M+H]+ 153.0659; found 153.0653. 
In an oven dried flask, 5-methyl-1-vinylpyrimidine-2,4(1H,3H)-dione (15) (920 mg, 6.05 mmol, 1 eq), 
di-tert-butyl dicarbonate (2.64 g, 12.1 mmol, 2 eq) and dimethylaminopyridine (1.48 g, 12.1 mmol, 2 
eq) were stirred in acetonitrile (25.0 mL) for 12 h. Silica was added to the reaction and the solvent was 
evaporated. The dry residue was loaded on a silica chromatography column and eluted with 
hexane/ethyl acetate/1% NEt3 (95:5 to 80:20) to provide tert-butyl 5-methyl-2,6-dioxo-3-vinyl-2,3-
dihydropyrimidine-1(6H)-carboxylate (4d) (1.15 g, 4.56 mmol, 75% yield) as a colorless solid. 
Rf 0.2 (Hexane/Ethyl acetate 9:1).  
Mp 109.9-111.2 °C.  
1H NMR (400 MHz, CDCl3) δ 7.31 (s, 1 H, C=C-H), 7.15 (dd, 1 H, J = 16.0, 9.1 Hz, -CH=C vinyl), 
5.09 (dd, 1 H, J = 16.0, 2.2 Hz, C=CH2 vinyl, trans), 4.94 (dd, 1 H, J = 9.1, 2.2 Hz, C=CH2 vinyl, cis), 
1.99 (s, 3 H), 1.60 (s, 9 H, Me).  
13C NMR (101 MHz, CDCl3) δ 161.0, 147.6, 147.5, 134.0, 129.6, 111.8, 101.3, 87.1, 27.5, 12.7. 
IR 2982 (w), 2937 (w), 1778 (s), 1721 (s), 1672 (s). 
HRMS (ESI) calcd for C12H16N2O4Na+ [M+Na]+ 275.1002; found 275.1008. 
(E)-2-(Prop-1-en-1-yl)isoindoline-1,3-dione (4f) 
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Following a modified procedure,3 allyl bromide (17) (2.6 mL, 30 mmol, 1.1 eq) was added dropwise at 
room temperature to a suspension of potassium phthalimide (16) (5.0 g, 27 mmol, 1 eq) and Bu4NI 
(0.50 g, 1.4 mmol, 0.05 eq) in DMF (10 mL). The mixture was stirred for 20 hours at room 
temperature, and then H2O (20 mL) was added. The precipitate was isolated by filtration, dried, and 
recrystallized from isopropanol to give 2-allylisoindoline-1,3-dione (18) (3.4 g, 18 mmol, 68% yield).  
2-Allylisoindoline-1,3-dione 18 (2.0 g, 11 mmol, 1 eq) was added in a sealed tube under nitrogen 
atmosphere to [RuCI2(PPh3)2] (0.10 g, 0.11 mmol, 0.01 eq). The solids were heated at 150 °C during 
12 hours and the reaction was cooled down to room temperature. The black mixture was dissolved in 
toluene and filtered on a celite pad. The solvents were evaporated and the brown orange solid was 
recrystallized in ethanol.(20 mL) of (E)-2-(prop-1-en-1-yl)isoindoline-1,3-dione (4f) (1.15 g, 6.10 
mmol, 58% yield) as a yellow solid were collected from the first recrystallization. 
1H NMR (400 MHz, CDCl3) δ 7.86 (dd, 2 H, J = 5.2, 3.1 Hz, Phth), 7.72 (dd, 2 H, J = 5.2, 3.0 Hz, 
Phth), 6.64-6.54 (m, 2 H, CH=CH), 1.85 (d, 3 H, J = 5.1 Hz, CH3). 
HRMS (ESI) calcd for C11H10NO2+ [M+H]+ 188.0706; found 188.0713. 
1H NMR data match literature report.3  
(E)-2-(Oct-1-en-1-yl)isoindoline-1,3-dione (4g) 
 
Following a modified procedure,4 phthalimide (19) (200 mg, 1.36 mmol, 1 eq), copper(II)acetate 
monohydrate (300 mg, 1.50 mmol, 1.1 eq), dichloromethane (2 mL) and triethylamine (379 µL, 2.72 
mmol, 2 eq) were added under air in a flask. Subsequently, (E)-oct-1-en-1-ylboronic acid (20) (212 
mg, 1.36 mmol, 1 eq) was added as a solid. The reaction was stirred for 12 hours. Volatiles were 
removed under reduced pressure and the crude was directly purified by Biotage (SNAP cartridge KP-
SIL 25 g, 95:5 to 4:6 Hexane/Ethyl acetate) to give (E)-2-(oct-1-en-1-yl)isoindoline-1,3-dione (4g) 
(127 mg, 0.490 mmol, 36% yield) as a pale yellow oil. 
Rf 0.6 (Hexane/Ethyl acetate 7/3). 
1H NMR (400 MHz, CDCl3) δ 7.89-7.81 (m, 2 H, Phth), 7.77-7.69 (m, 2 H, Phth), 6.61-6.57 (m, 2 H, 
CH=CH), 2.21-2.13 (m, 2 H, CH2), 1.51-1.41 (m, 2 H, CH2), 1.39-1.24 (m, 6 H, CH2), 0.89 (t, 3 H, J = 
7.0 Hz, CH3). 
13C NMR (101 MHz, CDCl3) δ 166.8, 134.3, 131.8, 123.5, 123.1, 117.5, 31.7, 31.2, 29.4, 28.9, 22.7, 
14.1. 
IR 2956 (w), 2929 (w), 2858 (w), 1779 (w), 1719 (s), 1387 (s). 
                                                          
3 Stojanovic, A.; Renaud, P.; Schenk, K. Helv. Chim. Acta, 2004, 81, 268. 
4. Lam, P. Y. S.; Vincent, G.; Bonne, D.; Clark, C. G. Tetrahedron Lett. 2003, 44, 4927 
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HRMS (ESI) calcd for C16H20NO2+ [M+H]+ 258.1489; found 258.1499. 
1.1. General procedure for the synthesis of (Z)-enimides 
 
Following a modified procedure,5 in the glovebox, bis-(2-methylallyl)cycloocta-1,5-diene ruthenium 
(12.8 mg, 0.0400 mmol, 0.02 eq), scandium triflate (39.4 mg, 0.0800 mmol, 0.04 eq) and imide (2.00 
mmol, 1 eq) were added in a microwave vial. The vial was sealed with a Teflon septum and 
subsequently, tri-n-butylphosphine (30.0 µL, 0.120 mmol, 0.06 eq), alkyne (4.00 mmol, 2 eq) and 
freshly distilled DMF (6 mL) were added. The solution was stirred at 60 °C for 15 h and then poured 
into an aqueous sodium bicarbonate solution (20 mL). The mixture was extracted twice with ethyl 
acetate (20 mL). The organic fractions were collected, washed with brine, dried over magnesium 
sulfate, filtered and concentrated under reduced pressure. The crude product was purified by Biotage 
(SNAP cartridge KP-SIL 25 g, 95:5 to 4:6 Hexane/Ethyl acetate).  
(Z)-2-Styrylisoindoline-1,3-dione ((Z)-4l) 
 
Phthalimide (294 mg, 2.00 mmol, 1 eq) and 1-hexyne (439 µl, 4.00 mmol, 2 eq) were combined to 
afford (Z)-2-styrylisoindoline-1,3-dione ((Z)-4l) (65 mg, 0.26 mmol, 13 % yield) as an orange solid. 
1H NMR (400 MHz, CDCl3) δ 7.91-7.85 (m, 2 H, Phth), 7.79-7.72 (m, 2 H, Phth), 7.28-7.22 (m, 5 H, 
ArH), 6.71 (d, 1 H, J = 9.1 Hz, CH=CH), 6.34 (d, 1 H, J = 9.1 Hz, CH=CH). 
HRMS (ESI) calcd for C16H12NO2+ [M+H]+ 250.0863; found 250.0851. 
1H NMR Data match literature report.5 
(Z)-1-(4-Phenylbut-1-en-1-yl)pyrrolidine-2,5-dione ((Z)-4k) 
 
Succinimide (198 mg, 2.00 mmol, 1 eq) and but-3-yn-1-ylbenzene (562 µL, 4.00 mmol, 2 eq) were 
combined to afford (Z)-1-(4-phenylbut-1-en-1-yl)pyrrolidine-2,5-dione ((Z)-4k) (400 mg, 1.75 mmol, 
87 % yield) as a brown light solid. 
                                                          
5 Gooßen, L. J.; Blanchot, M.; Brinkmann, C.; Gooßen, K.; Karch, R.; Rivas-Nass, A. J. Org. Chem. 2006, 71, 
9506. 
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1H NMR (400 MHz, CDCl3) δ 7.31-7.27 (m, 2 H, ArH), 7.22-7.16 (m, 3 H , ArH), 5.92 (d, 1 H, J = 
8.6 Hz , CH=CH), 5.76 (m, 1 H , CH=CH), 2.80-2.67 (m, 6 H , CH2), 2.28 (m, 2 H , CH2). 
HRMS (ESI) calcd for C14H16NO2+ [M+H]+ 230.1176; found 230.1175. 
1H NMR data match literature report.5 
1.2. General procedure for the synthesis of (E)-enimides. 
 
Following a modified procedure,5 bis-(2-methylallyl)cycloocta-1,5-diene ruthenium (31.9 mg, 0.100 
mmol, 0.05 eq), scandium triflate (39.4 mg, 0.0800 mmol, 0.04 eq) and imide (2.00 mmol, 1 eq) were 
added to a microwave vial in the glovebox. The vial was sealed with a Teflon septum and 
triisopropylphosphine (57.0 µL, 0.300 mmol, 0.15 eq), alkyne (4.00 mmol, 2 eq) and freshly distilled 
DMF (6 mL) were added. The solution was stirred at 60 °C for 15 h and then poured into an aqueous 
sodium bicarbonate solution (20 mL). The mixture was extracted twice with ethyl acetate (20 mL). 
The organic fractions were collected, washed with brine, dried over magnesium sulfate, filtered and 
concentrated under reduced pressure. The crude product was purified by Biotage (SNAP cartridge KP-
SIL 25 g, 95:5 to 4:6 Hexane/Ethyl acetate). 
(E)-2-(2-Cyclopropylvinyl)isoindoline-1,3-dione (4h) 
 
Phthalimide (294 mg, 2.00 mmol, 1 eq) and ethynylcyclopropane (339 µL, 4.00 mmol, 2 eq) were 
combined to afford (E)-2-(2-cyclopropylvinyl)isoindoline-1,3-dione (4h) (159 mg, 0.750 mmol, 37 % 
yield) as a yellow solid. 
Mp 92.2-94.3 °C. 
Rf 0.27 (Hexane/Ethyl acetate 7/3). 
1H NMR (400 MHz, CDCl3) δ 7.88-7.81 (m, 2 H, Phth), 7.76-7.68 (m, 2 H, Phth), 6.70 (d, 1 H, J = 
14.6 Hz, N-CH=), 6.20 (dd, 1 H, J = 14.6, 9.0 Hz, =CH-C), 1.48 (m, 1 H, CH cyclopropane), 0.87-
0.75 (m, 2 H, CH2 cyclopropane), 0.56-0.48 (m, 2 H, CH2 cyclopropane). 
13C NMR (101 MHz, CDCl3) δ 166.6, 134.2, 131.7, 126.6, 123.4, 115.7, 12.7, 6.9. 
IR 3080 (w), 3016 (w), 1773 (w), 1772 (w), 1713 (s), 1612 (w), 1468 (w), 1393 (s), 1308 (w), 1207 
(w), 1098 (w). 
HRMS (ESI) calcd for C13H12NO2+ [M+H]+ 214.0863; found 214.0854.  
(E)-2-(5-Chloropent-1-en-1-yl)isoindoline-1,3-dione (4i) 
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Phthalimide (294 mg, 2.00 mmol, 1 eq) and 5-chloropent-1-yne (427 µL, 4.00 mmol, 2 eq) were 
combined to afford (E)-2-(5-chloropent-1-en-1-yl)isoindoline-1,3-dione (4i) (77 mg, 0.31 mmol, 15 % 
yield) as a yellow solid. 
Mp 78.8-81.2 °C. 
Rf 0.35 (Hexane/Ethyl acetate 7/3). 
1H NMR (400 MHz, CDCl3) δ 7.86 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 7.73 (dd, J = 5.5, 3.1 Hz, 2H, 
Phth), 6.68 (dt, J = 14.6, 1.2 Hz, 1H, N-CH=), 6.56 (dt, J = 14.6, 7.2 Hz, 1H, =CH-C), 3.59 (dd, J = 
6.5 Hz, 6.5 Hz, 2H, CH2), 2.39 – 2.30 (m, 2H, CH2), 1.96 (dt, J = 7.9, 6.5 Hz, 2H, CH2). 
13C NMR (101 MHz, CDCl3) δ 166.6, 134.4, 131.6, 123.5, 120.4, 118.7, 44.2, 32.1, 28.23. 
IR 2958 (w), 2847 (w), 1780 (w), 1714 (s), 1613 (w), 1436 (w), 1384 (s), 1266 (m), 1113 (w).  
HRMS (ESI) calcd for C13ClH13NO2+ [M+H]+ 250.0629; found 250.0633. 
(E)-1-(Hex-1-en-1-yl)pyrrolidine-2,5-dione (4j) 
 
Succinimide (198 mg, 2.00 mmol, 1 eq) and hex-1-yne (463 µL, 4.00 mmol, 2 eq) were combined to 
afford (E)-1-(hex-1-en-1-yl)pyrrolidine-2,5-dione (4j) (242 mg,1.34 mmol, 67 % yield) as a brown oil. 
1H NMR (400 MHz, CDCl3) δ 6.61-6.55 (m, 1 H, CH=CH), 6.45-6.40 (m, 1 H, CH=CH), 2.72 (s, 4 H 
, CH2), 2.11 (qd, 2 H, J = 7.2, 1.1 Hz , CH2), 1.46-1.27 (m, 4 H , CH2), 0.89 (t, 3 H, J = 7.2 Hz , CH3).  
HRMS (ESI) calcd for C10H16NO2+ [M+H]+ 182.1176; found 182.1177. 
1H NMR data match literature report.5 
(E)-1-(4-Phenylbut-1-en-1-yl)pyrrolidine-2,5-dione (4k) 
 
Succinimide (198 mg, 2.00 mmol, 1 eq) and but-3-yn-1-ylbenzene (562 µL, 4.00 mmol, 2 eq) were 
combined to afford (E)-1-(4-phenylbut-1-en-1-yl)pyrrolidine-2,5-dione (4k) (209 mg, 0.910 mmol, 46 
% yield) as a brown light solid. 
1H NMR (400 MHz, CDCl3) δ 7.34-7.30 (m, 2 H, ArH), 7.25-7.19 (m, 3 H, ArH), 6.75-6.63 (m, 1 H , 
CH=CH), 6.50 (d, 1 H, J = 14.9 Hz , CH=CH), 2.82-2.72 (m, 6 H , CH2), 2.51-2.43 (m, 2 H , CH2). 
HRMS (ESI) calcd for C14H16NO2+ [M+H]+ 230.1176; found 230.1175. 
Data match literature report.5 
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1.3. General procedure for the synthesis of (E)-styrylphthalimide: 
 
Following a reported procedure,6 a mixture of aryl halide (4.00 mmol, 1 eq), N-vinylphthalimide (693 
mg, 4.00 mmol, 1 eq), Cy2NMe (1.17 g, 6.00 mmol, 1.5 eq), TBAB (1.29 g, 4.00 mmol, 1 eq) and 
palladium acetate (1.00 mg, 4.00 µmol, 0.001 eq) in DMF (8 mL) was heated at 120 °C (oil bath 
temperature) in a pressure tube after 5 cycles of vacuum/N2. When full conversion was observed by 
TLC, the yellow solution was poured into toluene (40 mL) and rinsed with toluene (10 mL). This 
solution was filtered through a pad of celite and concentrated under vacuum. To the yellow oil was 
added ethanol (20 mL). The product precipitated and was recovered by filtration after rinsing with 
ethanol. 
(E)-2-Styrylisoindoline-1,3-dione (4l) 
 
Phenyl iodide (816 mg, 4.00 mmol, 1 eq) was used and stirred 1h30 at 120 °C. (E)-2-styrylisoindoline-
1,3-dione (4l) (700 mg, 2.77 mmol, 69% yield) was obtained as a yellow powder. 
1H NMR (400 MHz, CDCl3) δ 7.91 (dd, 2 H, J = 5.5, 3.1 Hz, Phth), 7.77 (dd, 2 H, J = 5.4, 3.1 Hz, 
Phth), 7.66 (d, 1 H, J = 15.2 Hz, CH=CH), 7.51-7.45 (m, 2 H, ArH), 7.40-7.32 (m, 3 H, ArH), 7.30-
7.24 (m, 1 H, CH=CH). 
HRMS (ESI) calcd for C16H12NO2+ [M+H]+ 250.0863; found 250.0858. 
Data match literature report.7 
(E)-2-(4-Bromostyryl)isoindoline-1,3-dione (4m) 
 
1-Bromo-4-iodobenzene (1.13 g, 4.00 mmol, 1 eq) was used and stirred 3h30 at 120 °C. (E)-2-(4-
bromostyryl)isoindoline-1,3-dione (4m) (330 mg, 1.00 mmol, 25% yield) was obtained as a yellow 
powder. 
1H NMR (400 MHz, CDCl3) δ 7.95-7.88 (m, 2 H, Phth), 7.81-7.75 (m, 2 H, Phth), 7.60-7.54 (m, 1 H, 
CH=CH), 7.50-7.45 (m, 2 H, ArH), 7.38-7.31 (m, 3 H, ArH + CH=CH). 
13C NMR (101 MHz, CDCl3) δ 166.3, 135.0, 134.6, 131.8, 131.6, 127.7, 123.7, 121.4, 118.9, 118.1. 
                                                          
6 Alacid, E.; Nájera, C. Adv. Synth. Catal. 2008, 350, 1316. 
7 Susanto, W.; Chu, C.-Y.; Ang, W. J.; Chou, T.-C.; Lo, L.-C.; Lam, Y. J. Org. Chem. 2012, 77, 2729. 
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Data match literature report, with a slight shift in the carbon spectra for the area 127.7-121.4.8 
(E)-2-(2-Bromostyryl)isoindoline-1,3-dione (4n) 
 
1-Bromo-2-iodobenzene (1.13 g, 4.00 mmol, 1 eq) was used and stirred 3h30 at 120 °C. (E)-2-(2-
bromostyryl)isoindoline-1,3-dione (4n) (320 mg, 0.981 mmol, 24% yield) was obtained as a yellow 
powder after column chromatography Hexane:dichloromethane 95/5 to 1/1. 
Mp 193.2-194.6 °C. 
Rf 0.58 (Hexane/Ethyl acetate 7/3). 
1H NMR (400 MHz, CDCl3) δ 8.00 (d, 1 H, J = 15.0 Hz, CH=), 7.88-7.96 (m, 2 H, Phth), 7.74-7.82 
(m, 2 H, Phth), 7.55-7.63 (m, 2 H, Ar), 7.27-7.36 (m, 2 H, Ar + CH=), 7.10-7.17 (m, 1 H, Ar). 
13C NMR (101 MHz, CDCl3) δ 166.3, 136.3, 134.7, 133.1, 131.7, 128.9, 127.7, 126.4, 124.1, 123.8, 
119.6, 119.4. 
IR 1724 (s), 1645 (w), 1383 (s), 1100 (w), 1086 (w), 950 (w).  
HRMS (ESI) calcd for C1679BrH11NO2+ [M+H]+ 327.9968; found 327.9960. 
Data does not match literature report.6 
(E)-2-(4-(Trifluoromethyl)styryl)isoindoline-1,3-dione (4o) 
 
1-Iodo-4-(trifluoromethyl)benzene (1.08 g, 4.00 mmol, 1 eq) was used and stirred 1h30 at 120 °C. (E)-
2-(4-(trifluoromethyl)styryl)isoindoline-1,3-dione (4o) (679 mg, 2.14 mmol, 54% yield) was obtained 
as a yellow powder.  
1H NMR (400 MHz, CDCl3) δ 7.96-7.90 (m, 2 H, Phth), 7.83-7.76 (m, 2 H, Phth), 7.70 (d, 1 H, J = 
15.2 Hz, CH2), 7.63-7.54 (m, 4 H, ArH), 7.45 (d, 1 H, J = 15.2 Hz, CH=CH). 
HRMS (ESI) calcd for C17F3H11NO2+ [M+H]+ 318.0736; found 318.0724. 
Data match literature report.7 
(E)-2-(4-Methylstyryl)isoindoline-1,3-dione (4p) 
 
                                                          
8 Pawluć, P.; Franczyk, A.; Walkowiak, J.; Hreczycho, G.; Kubicki, M.; Marciniec, B.; Tetrahedron, 2012, 68, 
3545. 
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1-Iodo-4-methylbenzene (872 mg, 4.00 mmol, 1 eq) was used and stirred 3h30 at 120 °C. (E)-2-(4-
methylstyryl)isoindoline-1,3-dione (4p) (728 mg, 2.77 mmol, 69% yield) was obtained as a yellow 
powder. 
1H NMR (400 MHz, CDCl3) δ 7.93-7.88 (m, 2 H, Phth), 7.79-7.73 (m, 2 H, Phth), 7.63 (d, 1 H, J = 
15.2 Hz, CH=CH), 7.38 (d, 2 H, J = 8.1 Hz, ArH), 7.32 (d, 1 H, J= 15.2 Hz, CH=CH), 7.17 (d, 2 
H, J = 7.9 Hz, ArH), 2.36 (s, 3 H, CH3). 
HRMS (ESI) calcd for C17H14NO2+ [M+H]+ 264.1019; found 264.1022. 
Data match literature report.7  
(E)-2-(4-Methoxystyryl)isoindoline-1,3-dione (4q) 
 
1-Iodo-4-methoxybenzene (936 mg, 4.00 mmol, 1 eq) was used and stirred 1h30 at 120 °C. (E)-2-(4-
methoxystyryl)isoindoline-1,3-dione (4q) (780 mg, 2.79 mmol, 69% yield) was obtained as a yellow 
powder. 
1H NMR (400 MHz, CDCl3) δ 7.89 (dd, 2 H, J = 5.5, 3.1 Hz, Phth), 7.75 (dd, 2 H, J = 5.4, 3.0 Hz, 
Phth), 7.60 (d, 1 H, J = 15.2 Hz, CH=CH), 7.42 (d, 2 H, J = 8.6 Hz, ArH), 7.26-7.22 (m, 1 H, the 
doublet was covered by CDCl3 peak, CH=CH), 6.90 (d, 2 H, J = 8.8 Hz, ArH), 3.83 (s, 3 H, CH3). 
HRMS (ESI) calcd for C17H14NO3+ [M+H]+ 280.0968; found 280.0966. 
Data match literature report.7 
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2. Synthesis of methylene malonates 
Dimethyl 2-methylenemalonate (5a) 
 
Following a modified procedure,9 dry THF (200 mL), dimethyl malonate (7a) (18.3 g, 139 mmol, 
1eq), diisopropylamine 2,2,2-trifluoroacetate (29.9 g, 139 mmol, 1 eq), paraformaldehyde (8.35 g, 278 
mmol, 2 eq) and trifluoroacetic acid (1.07 mL, 13.9 mmol, 0.1 eq) were added to a 500 mL round 
bottom flask. A condenser was added and the suspension was stirred to reflux for two hours. 
Paraformaldehyde (8.35 g, 278 mmol, 2 eq) was added and the reflux was restarted for 6 hours. The 
reaction was cooled to room temperature and THF was removed under reduced pressure (300 to 50 
mbar at 45°C). The crude mixture was dissolved in diethyl ether (75 mL) and filtered through cotton in 
a separatory funnel. The organic layer was washed twice with 1 M HCl (50 mL). The aqueous layers 
were combined and extracted with diethyl ether (25 mL). The organic layers were combined, dried 
with anhydrous Na2SO4, filtered and concentrated under reduced pressure to give a colorless oil (30 g). 
The crude oil was purified by distillation (all the glassware needed for distillation had been washed 
with 2 M HCl, rinsed with methanol and dried in the oven at 110 °C prior to use). Dimethyl 2-
methylenemalonate (5a) (13.6 g, 94.0 mmol, 68% yield) was collected as a colorless oil between 45 
°C at 1.5 mbar and 50 °C at 1 mbar. The product was stored under nitrogen in a freezer and can be 
kept 2-3 weeks without major degradation. In case of degradation, a short path distillation was enough 
to obtain pure material. 
1H NMR (400 MHz, CDCl3) δ 6.45 (s, 2 H), 4.57 (s, 6 H). 
13C NMR (101 MHz, CDCl3) δ 164.38, 135.36, 134.14, 52.59. 
IR 1792 (w), 1736 (s), 1440 (m), 1340 (m), 1244 (s), 1128 (s). 
HRMS (ESI) calcd for C6H9O4+ [M+H]+ 145.0495; found 145.0502. 
Ethyl 2-benzoylacrylate (5c) 
 
Following a modified procedure,9 dry THF (20 mL), ethyl 3-oxo-3-phenylpropanoate (7b) (2.50 g, 
13.0 mmol, 1 eq), diisopropylamine 2,2,2-trifluoroacetate (2.80 g, 13.0 mmol, 1 eq), 
paraformaldehyde (780 mg, 27.0 mmol, 2eq) and trifluoroacetic acid (0.100 mL, 1.30 mmol, 0.1 eq) 
were added to a 50 mL round bottom flask. A condenser was added and the suspension was stirred to 
reflux for two hours. Paraformaldehyde (780 mg, 27.0 mmol, 2 eq) was added and the reflux was 
restarted for 6 hours. The reaction was cooled to room temperature and THF was removed under 
reduced pressure. The crude was dissolved in diethyl ether (20 mL) and filtered through cotton in a 
                                                          
9 Bugarin, A.; Jones, K. D.; Connell, B. T. Chem. Commun. 2010, 46, 1715. 
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separatory funnel. The organic layer was washed twice with 1 M HCl (20 mL). The aqueous layers 
were combined and extracted with diethyl ether (20 mL). The organic layers were combined, dried 
over anhydrous Na2SO4, filtered and concentrated under reduced pressure to give a yellow oil. The 
crude oil was purified by column chromatography on Biotage (SNAP cartridge KP-SIL 50 g, 95:5 to 
4:6 Hexane/Ethyl acetate) affording ethyl 2-benzoylacrylate (5c) (1.75 g, 8.57 mmol, 66 % yield) as a 
pale yellow oil. 
1H NMR (400 MHz, CDCl3) δ 7.86 (dd, J = 8.4, 1.4 Hz, 2H, ArH), 7.65-7.56 (m, 1H, ArH), 7.51-7.42 
(m, 2H, ArH), 6.70 (d, J = 0.8 Hz, 1H, C=CH2), 6.07 (d, J = 0.8 Hz, 1H, C=CH2), 4.23 (q, J = 7.1 Hz, 
2H, CH2), 1.20 (t, J = 7.2 Hz, 3H, CH3). 
HRMS (ESI) calcd for C12H13O3+ [M+H]+ 205.0859; found 205.0867.  
Data match literature report.10 
Dimethyl 2-(3-phenylpropylidene)malonate (5d) 
 
Following a modified reported procedure,11 dimethyl malonate (7a) (661 mg, 5.00 mmol, 1 eq), acetic 
anhydride (708 µL, 7.50 mmol, 1.5 eq) and 3-phenylpropanal (21) (1.33 mL, 10.0 mmol, 2 eq) were 
added in a microwave vial. The vial was sealed and the reaction was stirred 24 hours at 110 °C. 
Evaporation of the acetic anhydride on the rotary evaporator and high vacuum afforded an oil that was 
purified by column chromatography on Biotage (SNAP cartridge KP-SIL 25 g, 98:2 Hexane/Ethyl 
acetate to 95:5 Hexane/Ethyl acetate). Dimethyl 2-(3-phenylpropylidene)malonate (5d) (690 mg, 2.78 
mmol, 56 % yield) was obtained as a yellow oil. 
1H NMR (400 MHz, CDCl3) δ 7.33 – 7.27 (m, 2H, ArH), 7.24 – 7.16 (m, 3H, ArH), 7.07 (dd, J = 7.7, 
7.7 Hz, 1H, C=CH), 3.81 – 3.75 (m, 6H, OCH3), 2.80 (dd, J = 8.7, 6.7 Hz, 2H, CH2), 2.63 (dd, J = 7.6, 
7.6 Hz, 2H, CH2). 
HRMS (ESI) calcd for C14H16NaO4+ [M+Na]+ 271.0941; found 271.0933. 
Data match literature report.12 
Dimethyl 2-(cyclohexylmethylene)malonate (5e) 
 
Dimethyl malonate (7a) (2.14 g, 16.2 mmol, 1 eq), AcOH (30 mL), cyclohexanecarbaldehyde (22) 
(2.00 g, 17.8 mmol, 1 eq) and ammonium acetate (1.37 g, 17.8 mmol, 1.1 eq) were added to a 50 mL 
                                                          
10 De Fusco, C.; Fuoco, T.; Croce, G.; Lattanzi, A. Org. Lett. 2012, 14, 4078. 
11 Jabin I.; Revial G.; Monnier-Benoit N.; Netchitailo P. J. Org. Chem. 2001, 66, 256. 
12 Nickerson, D. M.; Mattson. A. E. Chem. Eur. J. 2012, 18, 8310. 
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round bottom flask. A condenser was added and the suspension was stirred at 60 °C for 20 hours. The 
reaction was poured in brine (25 mL) and extracted with ethyl acetate (50 mL). The organic layer was 
washed three times with brine (25 mL), dried over anhydrous Na2SO4, filtered and concentrated under 
reduced pressure. The crude product was purified by column chromatography (SiO2, Hexane/Ethyl 
Acetate 95:5) affording dimethyl 2-(cyclohexylmethylene)malonate (5e) (2.80 g, 12.4 mmol, 76 % 
yield) as a yellow oil. 
1H NMR (400 MHz, CDCl3) δ 6.85 (d, J = 10.4 Hz, 1H, C=CH), 3.83 (s, 3H, OCH3), 3.77 (s, 3H, 
OCH3), 2.37 (dtt, J = 14.1, 6.6, 3.5 Hz, 1H, CH), 1.79 – 1.61 (m, 5H, CH2), 1.36 – 1.08 (m, 5H, CH2). 
HRMS (ESI) calcd for C12H19O4+ [M+H]+ 227.1278; found 227.1280. 
Data match literature report.13 
Dibenzyl 2-ethylidenemalonate (5f) 
 
Following a modified reported procedure,11 dibenzyl malonate (7c) (2.00 g, 7.03 mmol, 1 eq), acetic 
anhydride (1.08 g, 10.6 mmol, 1.5 eq) and acetaldehyde (23) (1.55 g, 35.2 mmol, 5 eq) were added in 
a microwave vial. The vial was sealed and the reaction was stirred 24 hours at 85 °C. Evaporation of 
the acetic anhydride on the rotary evaporator and high vacuum afforded an oil that was purified by 
column chromatography on Biotage (SNAP cartridge KP-SIL 50 g, 95:2 to 7:3 Hexane/Ethyl acetate). 
Dibenzyl 2-ethylidenemalonate (5f) (1.10 g, 3.54 mmol, 50 % yield + some traces of malonate left) 
was obtained as a colorless oil. 
Rf 0.6 (Hexane/Ethyl acetate 7/3). 
1H NMR (400 MHz, CDCl3) δ 7.39 – 7.30 (m, 10H, ArH), 7.18 (q, J = 7.3 Hz, 1H, =CH), 5.28 (s, 2H, 
CH2Ar), 5.22 (s, 2H, CH2Ar), 1.96 (d, J = 7.3 Hz, 3H, Me). 
13C NMR (101 MHz, CDCl3) δ 165.07, 163.64, 146.33, 135.53, 135.37, 129.05, 128.57, 128.52, 
128.42, 128.30, 128.21, 128.04, 67.04, 66.85, 15.66. 
IR 3066 (w), 3035 (w), 2954 (w), 1731 (s), 1499 (w), 1262 (s), 1216 (s), 1138 (m), 1050 (m), 1003 
(w), 744 (m). 
HRMS (ESI) calcd for C19H19O4+ [M+H]+ 311.1278; found 311.1281. 
Dibenzyl 2-(2,2,2-trifluoroethylidene)malonate (5g) 
 
Dibenzyl malonate (7c) (300 mg, 1.06 mmol, 1 eq), acetic anhydride (500 µL, 5.28 mmol, 5 eq) and 1-
ethoxy-2,2,2-trifluoroethan-1-ol (24) (368 µL, 3.17 mmol, 3 eq) were added in a microwave vial. The 
vial was sealed and the reaction was stirred 18 hours at 100 °C. After going back to room temperature 
the reaction was transferred into a separatory funnel and sat.NaHCO3 (15 mL) and diethyl ether (20 
                                                          
13 Nickerson, D. M.; Mattson. A. E. Chem. Eur. J. 2012, 18, 8310. 
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mL) were added. The layers were separated and the organic layer was dried over anhydrous Na2SO4. 
The solvents were evaporated under reduced pressure and the obtained oil was purified by column 
chromatography on Biotage (SNAP cartridge KP-SIL 25 g, 98:2 to 95:5 Hexane/Ethyl acetate). 
Dibenzyl 2-(2,2,2-trifluoroethylidene)malonate (5g) (162 mg, 0.401 mmol, 90 % yield, 90% pure by 
NMR) was obtained as a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 7.34 – 7.20 (m, 10H, ArH), 6.73 (q, J = 7.5 Hz, 1H, C=CH), 5.21 (s, 
2H, CH2), 5.18 (s, 2H, CH2). 
19F NMR (376 MHz, CDCl3) δ -62.3. 
Data match literature report.14  
                                                          
14 L. Wen, Q. Shen, L. Lu, Org. Lett. 2010, 12, 4655. 
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3. Screening of Lewis acids 
 
Entry Cat.(mol %) t (h) R T°C Conversion
[a]
 
1 ZnBr2 (100) 1 R
1=Me, R2=H (5/7) -78 0 
2 Yb(OTf)3 (10) 0.75 R
1=Me, R2=H (5/7) -78 0 
3 Sc(OTf)3 (10) 0.75 R
1=Me, R2=H (5/7) -78 traces 
4 Sc(OTf)3 (10) 0.75 R
1=Me, R2=H (5/7) -30 35 
5 Sc(OTf)3 (10) 0.5 R
1=Me, R2=H (5/7) 0 100 
6 Sc(OTf)3 (20) 12 R
1=Et, R2=Me (6/8) rt 0 
7 In(OTf)3 (20) 12 R
1=Et, R2=Me (6/8) rt 60 
8 FeCl3.Al2O3 (20) 12 R
1=Et, R2=Me (6/8) rt 100 
 
Reaction with ZnBR2: 
The reaction vessel was washed with aq HCl, rinsed with MeOH and dried in the oven. 
Following a modified procedure15, ZnBr2 (247 mg, 1.10 mmol, 1.6 eq) was added in a flask and 
dichloromethane (1.5 mL) was added. Vinyl phthalimide (228 mg, 1.30 mmol, 1.9 eq) was dissolved 
in a second flask and dichloromethane (1.5 mL) was added. Dimethyl 2-methylenemalonate (100 mg, 
0.694 mmol, 1eq) was added in a third flask and dissolved in dichloromethane (1.5 mL). 
The flask containing the ZnBr2 solution was cooled down to -130 °C with heptane/liq N2. The 
dimethyl 2-methylenemalonate solution and the vinyl phthalimide solution were then slowly 
cannulated to the reaction mixture. The solvents were solid under these conditions. 
The flask was warmed to -78 °C. When the solution became liquid again, the reaction was stirred for 1 
hour at -78 °C. Pyridine (0.4 mL) in dichloromethane (1 mL) cooled to -78 °C was added to give an 
orange solution whichwas warmed to room temperature. A saturated Rochelle salt solution was added 
and the layers were separated. The organic layer was dried over MgSO4 and evaporated. The crude 
mixture was analyzed by 1H NMR and only vinyl phthalimide was observed. 
Reaction with Yb(OTf)3, Sc(OTf)3 and diethyl 2-ethylidenemalonate (5b): 
The Lewis acid (0.014 mmol, 0.1 eq) was weighted in the glovebox and dry dichloromethane (200 µL) 
was added. The reaction was cooled at the indicated temperature. Diethyl 2-ethylidenemalonate (20.0 
mg, 0.139 mmol, 1 eq) and 2-vinylisoindoline-1,3-dione (18.5 mg, 0.167 mmol, 1.2 eq) were 
dissolved in dry dichloromethane (800 µL) and the resulting solution was added dropwise via syringe 
pump for the indicated time. After the addition was complete, the reaction was filtered over a pad of 
alumina, eluted with ethyl acetate and concentrated under vacuum. The crude product was analyzed by 
1H NMR. 
Reaction with In(OTf)3, Sc(OTf)3 and FeCl3.Al2O3 and dimethyl 2-ethylidenemalonate: 
The Lewis acid (0.012 mmol, 0.2 eq) was weighted in the glovebox and dry dichloromethane (0.20 
mL) was added. Dimethyl 2-ethylidenemalonate (13 mg, 0.087 mmol, 1 eq) and 2-vinylisoindoline-
1,3-dione (10 mg, 0.058 mmol, 1 eq) were dissolved in dry dichloromethane (0.80 mL) and added 
dropwise. After stirring for the indicated time, the reaction was filtered over a pad of alumina, eluted 
with ethyl acetate and concentrated under vacuum. The crude product was analyzed by 1H NMR.  
                                                          
15 A. T. Parsons, J. S. Johnson, J. Am. Chem. Soc. 2009, 131, 14202 
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4. Synthesis of cyclobutanes 
 
4.1. General procedure A for the synthesis of cyclobutanes  
In the glovebox, iron trichloride supported on alumina (1.00 mmol/g, 20.0 mg, 0.0200 mmol, 0.1 eq) 
was added to a microwave vial. The vial was sealed with a Teflon septum and taken out of the 
glovebox. Dry dichloromethane (200 µL) was added and the yellow suspension was cooled to 0 °C. 
The methylene malonate (0.400 mmol, 2 eq) and vinyl amide (0.200 mmol, 1 eq) were dissolved in 
dry dichloromethane (800 µL). The solution was then added dropwise to the iron trichloride. The 
reaction was stirred at 0 °C or room temperature and the conversion was followed by TLC 
(Hexane/Ethyl Acetate 7:3). When full conversion of the vinyl compound was observed, the reaction 
was filtered over a pad of alumina, eluted with ethyl acetate and concentrated under vacuum. The 
crude product was purified by column chromatography using the indicated solvents. 
4.2. General procedure B for the synthesis of cyclobutanes  
In the glovebox, iron trichloride supported on alumina (1.00 mmol/g, 20.0 mg, 0.0200 mmol, 0.1 eq) 
was added to a microwave vial. The vial was sealed with a Teflon septum and took out of the 
glovebox. Dry dichloromethane (200 µL) was added. The methylene malonate (0.40 mmol, 2 eq) and 
vinyl amide (0.200 mmol, 1 eq) were dissolved in dry dichloromethane (800 µL). The solution was 
then added dropwise to the iron trichloride. The reaction was stirred at room temperature and the 
conversion was followed by TLC (Hexane/Ethyl Acetate 7:3). When full conversion of the vinyl 
compound was observed, the reaction was filtered over a pad of alumina, eluted with ethyl acetate and 
concentrated under vacuum. The crude product was purified by column chromatography as indicated. 
4.3. General procedure C for the synthesis of cyclobutanes  
In the glovebox, iron trichloride supported on alumina (1.00 mmol/g, 20.0 mg, 0.0200 mmol, 0.1 eq) 
was added to a microwave vial. The vial was sealed with a Teflon septum and took out of the 
glovebox. Dry dichloromethane (200 µL) was added and the vinyl amide (0.200 mmol, 1 eq) was 
dissolved in dry dichloromethane (500 µL) and added to the iron trichloride. The methylene malonate 
(0.400 mmol, 2 eq or 0.800 mmol, 4 eq) was dissolved in dry dichloromethane (300 µL) and added 
dropwise over 2 hours. When the addition was finished, the reaction was stirred at room temperature 
until TLC indicated that no more starting material was present. The reaction was filtered over a pad of 
alumina, eluted with ethyl acetate and concentrated under vacuum. The crude product was purified by 
column chromatography. 
Dimethyl 2-(1,3-dioxoisoindolin-2-yl)cyclobutane-1,1-dicarboxylate (6aa) 
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Using general procedure A, 2-vinylisoindoline-1,3-dione (34.6 mg, 0.200 mmol) and dimethyl 2-
methylenemalonate (57.7 mg, 0.400 mmol) were stirred for 20 minutes at 0 °C. The crude oil was 
purified by column chromatography on Biotage (SNAP cartridge KP-SIL 10 g, 95:5 to 5:5 
Hexane/Ethyl acetate) affording cyclobutane 6aa (61.1 mg, 0.190 mmol, 96 % yield) as a colorless 
solid. 
Rf 0.45 (Hexane/Ethyl acetate 1/1). 
Mp 124.1-126.3 °C. 
1H NMR (400 MHz, CDCl3) δ 7.93 (m, 2 H, Phth), 7.80 (m, 2 H, Phth), 5.17 (t, 1 H, J = 10.9 Hz, N-
C-H), 3.16 (s, 3 H, CO2CH3), 2.98 (s, 3 H, CO2CH3), 2.58 (m, 1 H, CH2), 2.25 (m, 1 H, CH2), 1.48 (m, 
1 H, CH2), 1.33 (dt, 1 H, J = 13.6, 10.4 Hz, CH2). 
13C NMR (101 MHz, CDCl3) δ 170.6, 168.7, 168.3, 134.3, 131.9, 123.5, 59.0, 53.2, 53.0, 47.9, 24.7, 
21.9. 
IR 2956 (w), 2848 (w), 1782 (w), 1781 (w), 1741 (s), 1721 (s), 1437 (w), 1378 (m), 1266 (m). 
HRMS (ESI) calcd for C16H16NO6+ [M+H]+ 318.0972; found 318.0978. 
Dimethyl 2-(2,5-dioxopyrrolidin-1-yl)cyclobutane-1,1-dicarboxylate (6ba) 
 
Using general procedure A, 1-vinylpyrrolidine-2,5-dione (25.0 mg, 0.200 mmol) and dimethyl 2-
methylenemalonate (57.7 mg, 0.400 mmol) were stirred for 30 minutes at 0 °C. The crude oil was 
purified by column chromatography on Biotage (SNAP cartridge KP-SIL 10 g, 95:5 to 4:6 
Hexane/Ethyl acetate) affording cyclobutane 6ba (48.8 mg, 0.180 mmol, 91 % yield) as a colorless oil. 
Rf 0.35 (Hexane/Ethyl acetate 6/4).  
1H NMR (400 MHz, CDCl3) δ 5.30 (dd, 1 H, J = 9.2, 9.2 Hz, N-C-H), 3.74 (s, 3 H, CO2CH3), 3.70 (s, 
3 H, CO2CH3), 3.18-3.03 (m, 1 H, CH2), 2.98-2.86 (m, 1 H, CH2), 2.77-2.55 (m, 4 H, Succinimide), 
2.26-2.11 (m, 2 H, CH2). 
13C NMR (101 MHz, CDCl3) δ 177.1, 170.5, 168.6, 57.7, 53.1, 52.9, 48.2, 28.0, 24.8, 20.7. 
IR 2956 (w), 2848 (w), 1778 (w), 1736 (s), 1706 (s), 1436 (m), 1378 (s), 1262 (s), 1198 (m), 1116 (s). 
HRMS (ESI) calcd for C12H15NNaO6+ [M+Na]+ 292.0792; found 292.0799.  
Dimethyl 2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)cyclobutane-1,1-dicarboxylate (6ca) 
 
Using general procedure A, 1-vinyl-1H-pyrrole-2,5-dione (24.6 mg, 0.200 mmol) and dimethyl 2-
methylenemalonate (57.7 mg, 0.400 mmol) were stirred for 60 minutes at 0 °C. The crude oil was 
purified by column chromatography on Biotage (SNAP cartridge KP-SIL 10 g, 95:5 to 4:6 
Hexane/Ethyl acetate) affording cyclobutanes 6ca (28.2 mg, 0.100 mmol, 48 % yield) as a colorless 
oil. 
Rf 0.19 (Hexane/Ethyl acetate 7/3).  
19 
 
1H NMR (400 MHz, CDCl3) δ 6.68 (s, 2 H, Maleimide), 5.27 (dd, 1 H, J = 9.4, 9.4 Hz, N-C-H), 3.74 
(s, 3 H, CO2CH3), 3.67 (s, 3 H, CO2CH3), 3.14 (m, 1 H, CH2), 2.88 (m, 1 H, CH2), 2.25 (m, 1 H, CH2), 
2.13 (m, 1 H, CH2).  
13C NMR (101 MHz, CDCl3) δ 170.5, 170.4, 168.5, 134.2, 58.8, 53.1, 53.0, 47.5, 24.3, 21.7. 
IR 2958 (w), 1736 (s), 1709 (s), 1437 (w), 1405 (w), 1379 (m), 1265 (s), 1107 (m).  
HRMS (ESI) calcd for C12H13NNaO6+ [M+Na]+ 290.0635; found 290.0629.  
Dimethyl 2-(3-(tert-butoxycarbonyl)-5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-
yl)cyclobutane-1,1-dicarboxylate (6da) 
 
Using general procedure A, (tert-butyl 5-methyl-2,6-dioxo-3-vinyl-2,3-dihydropyrimidine-1(6H)-
carboxylate (50.5 mg, 0.200 mmol) and dimethyl 2-methylenemalonate (57.7 mg, 0.400 mmol) were 
stirred for 3 hours at room temperature. The crude oil was purified by column chromatography on 
Biotage (SNAP cartridge KP-SIL 10 g, 95:5 to 4:6 Hexane/Ethyl acetate) affording cyclobutane 6da 
(60.0 mg, 0.150 mmol, 76 % yield) as a colorless oil. 
Rf 0.18 (Hexane/Ethyl acetate 6/4). 
1H NMR (400 MHz, CDCl3) δ 7.05 (s, 1 H, C=CH), 5.22 (dd, 1 H, J = 9.5, 9.5 Hz, N-C-H), 3.76 (s, 3 
H, CO2CH3), 3.69 (s, 3 H, CO2CH3), 2.96-2.84 (m, 1 H, CH2), 2.81-2.72 (m, 1 H, CH2), 2.38-2.27 (m, 
1 H, CH2), 2.18-2.07 (m, 1 H, CH2), 1.92 (s, 3 H, Me), 1.59 (s, 9 H, Boc). 
13C NMR (101 MHz, CDCl3) δ 170.1, 168.5, 161.3, 149.1, 147.8, 138.0, 110.0, 86.7, 59.1, 56.2, 53.2, 
53.1, 27.5, 23.6, 22.9, 12.5. 
IR 2984 (w), 2957 (w), 1784 (m), 1734 (s), 1713 (m), 1667 (s), 1437 (m), 1371 (m), 1263 (s), 1238 
(s), 1147 (s), 1108 (m).  
HRMS (ESI) calcd for C18H25N2O8+ [M+H]+ 397.1605; found 397.1605. 
Ethyl 1-benzoyl-2-(1,3-dioxoisoindolin-2-yl)cyclobutane-1-carboxylate (6ac) 
 
Using general procedure A, 2-vinylisoindoline-1,3-dione (34.6 mg, 0.200 mmol) and dimethyl 2-
methylenemalonate (82.0 mg, 0.400 mmol) were stirred for 4 hours at 0 °C. The crude oil was purified 
by column chromatography on Biotage (SNAP cartridge KP-SIL 10 g, 95:5 to 4:6 Hexane/Ethyl 
acetate) affording cyclobutane 6ac (46.8 mg, 0.120 mmol, 62 % yield, 2.5:1 dr determined by 
integration of the peaks at 3.31-3.23 (maj), and 3.04-2.93(min) in the crude 1H NMR) as a colorless 
oil. 
Rf 0.35 (Hexane/Ethyl acetate 7/3). 
1H NMR (400 MHz, CDCl3) on a 3(maj.):1(min.) mixture δ 7.91-7.82 (m, 12 H, Phth and Ar maj.), 
7.75-7.68 (m, 6 H, Phth maj.), 7.64-7.56 (m, 6 H, Phth and Ar min.), 7.56-7.50 (m, 4 H, Ar maj.), 
7.44-7.39 (m, 6 H, Ar maj.), 7.20-7.10 (m, 3 H, Ar min.), 5.85-5.80 (m, 1 H, N-C-H min.), 5.76 (dd, 3 
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H, J = 9.5, 9.5 Hz, N-C-H maj.), 4.19 (qd, 2 H, J = 7.1, 1.4 Hz, COOEt min.), 4.00-3.85 (m, 6 H, 
COOEt maj.), 3.51-3.37 (m, 4 H, CH2 maj. and min.), 3.31-3.23 (m, 3 H, CH2 maj.), 3.04-2.93 (m, 1 
H, CH2 min.), 2.56-2.44 (m, 1 H, CH2 min.), 2.33-2.23 (m, 4 H, CH2 maj. and min.), 2.22-2.14 (m, 3 
H, CH2 maj.), 1.11 (t, 3 H, J = 7.1 Hz, COOEt min.), 0.77 (t, 10 H, J= 7.2 Hz, COOEt maj.). 
13C NMR (101 MHz, CDCl3) maj. δ 193.5, 169.1, 168.2, 134.2, 133.9, 133.5, 131.8, 129.0, 128.7, 
123.4, 65.6, 62.1, 46.9, 25.3, 22.0, 13.5 
13C NMR (101 MHz, CDCl3) min. δ 192.7, 171.7, 167.9, 135.4, 133.9, 132.6, 131.3, 128.5, 128.2, 
123.0, 62.2, 62.0, 48.2, 25.5, 21.8, 13.9. 
IR 1780 (w), 1734 (s), 1719 (s), 1436 (w), 1377 (s), 1263 (s), 1200 (w).  
HRMS (ESI) calcd for C22H20NO5+ [M+H]+ 378.1336; found 378.1338. 
Stereochemistry was assigned by 2D ROESY NMR experiment. 
 
Dimethyl 2-(1,3-dioxoisoindolin-2-yl)-3-methylcyclobutane-1,1-dicarboxylate (6fa) 
 
Using general procedure A, (E)-2-(prop-1-en-1-yl)isoindoline-1,3-dione (37.4 mg, 0.200 mmol) and 
dimethyl 2-methylenemalonate (57.7 mg, 0.400 mmol) were stirred for 20 minutes at 0 °C. The crude 
oil was purified by column chromatography on Biotage (SNAP cartridge KP-SIL 10 g, 95:5 to 4:6 
Hexane/Ethyl acetate) affording cyclobutane 6fa (55.2 mg 0.170 mmol, 83 % yield) as a colorless 
solid. The product was recrystallized in ethanol.16 
Rf 0.26 (Hexane/Ethyl acetate 7/3). 
Mp 112.1-114.3 °C. 
1H NMR (400 MHz, CDCl3) δ 7.83 (m, 2 H, Phth), 7.72 (m, 2 H, Phth), 4.96 (d, 1 H, J = 10.3 Hz, N-
C-H), 3.71 (m, 4 H, CO2CH3 and C-H-CH3), 3.60 (s, 3 H, CO2CH3), 3.00 (dd, 1H, J = 10.9, 9.3 Hz, 
CH2), 1.74 (dd, 1 H, J = 11.5, 9.5 Hz, CH2), 1.16 (d, 3 H, J = 6.6 Hz, CH3). 
13C NMR (101 MHz, CDCl3) δ 170.4, 168.6, 168.3, 134.2, 131.8, 123.4, 56.3, 54.9, 53.0, 52.9, 32.1, 
29.9, 19.3. 
IR 3006 (w), 2955 (w), 2869 (w), 1780 (w), 1735 (s), 1716 (s), 1437 (w), 1379 (s), 1261 (s). 
HRMS (ESI) calcd for C17H18NO6+ [M+H]+ 332.1129; found 332.1124. 
Dimethyl 2-(1,3-dioxoisoindolin-2-yl)-3-hexylcyclobutane-1,1-dicarboxylate (6ga) 
                                                          
16 The crystal structure has been deposited at the Cambridge Crystallographic Data Centre and allocated the 
deposition number CCDC 933180. 
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Using general procedure A, (E)-2-(oct-1-en-1-yl)isoindoline-1,3-dione (51.5 mg, 0.200 mmol) and 
dimethyl 2-methylenemalonate (57.7 mg, 0.400 mmol) were stirred for 60 minutes at room 
temperature. The crude oil was purified by column chromatography on Biotage (SNAP cartridge KP-
SIL 10 g, 95:5 to 4:6 Hexane/Ethyl acetate) affording cyclobutane 6ga (68.2 mg, 0.170 mmol, 85 % 
yield) as a colorless oil. 
Rf 0.3 (Hexane/Ethyl acetate 7/3). 
1H NMR (400 MHz, CDCl3) δ 7.86-7.80 (m, 2 H, Phth), 7.74-7.69 (m, 2 H, Phth), 5.03 (d, 1 H, J = 
10.2 Hz, N-C-H), 3.73 (s, 3 H, CO2CH3), 3.54-3.65 (m, 4 H, CO2CH3 + CH2 cyclobutane), 2.99 (ddd, 
1 H, J = 11.4, 9.3, 0.5 Hz, CH2 cyclobutane), 1.73 (dd, 1 H, J = 11.5, 9.3 Hz, CH2 cyclobutane), 1.60-
1.40 (m, 2 H, CH2 hexyl), 1.25-1.10 (m, 8 H, CH2 hexyl), 0.84-0.74 (m, 3 H, CH3 hexyl). 
13C NMR (101 MHz, CDCl3) δ 170.4, 168.6, 168.2, 134.2, 131.7, 123.4, 56.1, 53.6, 53.0, 53.0, 34.8, 
34.7, 31.7, 30.7, 29.1, 26.6, 22.5, 14.0. 
IR 2955 (w), 2925 (w), 2855 (w), 1781 (w), 1738 (s), 1716 (s). 
HRMS (ESI) calcd for C22H28NO6+ [M+H]+ 402.1911; found 402.1914. 
Dimethyl -3-cyclopropyl-2-(1,3-dioxoisoindolin-2-yl)cyclobutane-1,1-dicarboxylate (6ha) 
 
Using general procedure B, (E)-2-(2-Cyclopropylvinyl)isoindoline-1,3-dione (42.6 mg, 0.200 mmol) 
and dimethyl 2-methylenemalonate (57.7 mg, 0.400 mmol) were stirred for 60 minutes at room 
temperature. The crude oil was purified by column chromatography on Biotage (SNAP cartridge KP-
SIL 10 g, 95:5 to 4:6 Hexane/Ethyl acetate) affording cyclobutane 6ha (53.1 mg, 0.150 mmol, 74 % 
yield) as a colorless oil. 
Rf 0.20 (Hexane/Ethyl acetate 7/3). 
1H NMR (400 MHz, CDCl3) δ 7.84 (dd, J = 5.4, 3.1 Hz, 2H, Phth), 7.72 (dd, J = 5.5, 3.0 Hz, 2H, 
Phth), 5.10 (d, J = 10.4 Hz, 1H, N-C-H), 3.75 (s, 3H, CO2CH3), 3.59 (s, 3H, CO2CH3), 3.36-3.20 (m, 
1H, CH2 cyclobutane), 2.92 (dd, J = 11.3, 9.4 Hz, 1H, CH2 cyclobutane), 1.83 (dd, J = 11.5, 9.6 Hz, 
1H, CH2 cyclobutane), 0.85 (qt, J = 8.1, 4.9 Hz, 1H, CH cyclopropane), 0.55-0.27 (m, 2H, CH2 
cyclopropane), 0.23-0.04 (m, 2H, CH2 cyclopropane). 
13C NMR (101 MHz, CDCl3) δ 170.4, 168.7, 168.4, 134.3, 131.9, 123.5, 56.0, 53.1, 53.1, 53.0, 38.4, 
29.8, 13.6, 2.7, 2.6. 
IR 3081 (w), 3005 (w), 2957 (w), 1779 (w), 1737 (s), 1715 (s), 1436 (m), 1377 (s), 1265 (s), 1199 
(m), 1144 (m), 1049 (w). 
HRMS (ESI) calcd for C19H20NO6+ [M+H]+ 358.1285; found 358.1283.  
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Dimethyl 3-(3-chloropropyl)-2-(1,3-dioxoisoindolin-2-yl)cyclobutane-1,1-dicarboxylate (6ia) 
 
Using general procedure B, (E)-2-(5-chloropent-1-en-1-yl)isoindoline-1,3-dione (49.9 mg, 0.200 
mmol) and dimethyl 2-methylenemalonate (57.7 mg, 0.400 mmol) were stirred for 60 minutes at room 
temperature. The crude oil was purified by column chromatography on Biotage (SNAP cartridge KP-
SIL 10 g, 95:5 to 4:6 Hexane/Ethyl acetate) affording cyclobutane 6ia (75.1 mg, 0.190 mmol, 95 % 
yield) as a colorless oil. 
Rf 0.25 (Hexane/Ethyl acetate 7/3). 
1H NMR (400 MHz, CDCl3) δ 7.89-7.81 (m, 2 H, Phth), 7.78-7.69 (m, 2 H, Phth), 5.06 (d, 1 H, J = 
10.1 Hz, N-C-H), 3.75 (s, 3 H, CO2CH3), 3.71-3.57 (m, 4 H, CO2CH3 + Ar-C-H), 3.52-3.43 (m, 2 H, 
CH2-Cl), 3.03 (dd, 1 H, J = 11.3, 9.5 Hz, CH2 cyclobutane), 1.78 (dd, 1 H, J = 11.5, 9.3 Hz, CH2 
cyclobutane), 1.74-1.65 (m, 4 H, CH2 alkyl chain). 
13C NMR (101 MHz, CDCl3) δ 170.2, 168.4, 168.2, 134.3, 131.7, 123.4, 56.0, 53.5, 53.1, 53.0, 44.6, 
34.1, 33.0, 30.6, 29.8. 
IR 2954 (w), 1781 (w), 1736 (s), 1714 (s), 1436 (w), 1378 (s), 1263 (s), 1262 (s), 1200 (m), 1072 (m). 
HRMS (ESI) calcd for C19ClH21NO6+ [M+H]+ 394.1052; found 394.1053. 
Dimethyl -3-butyl-2-(2,5-dioxopyrrolidin-1-yl)cyclobutane-1,1-dicarboxylate (6ja) 
 
Using general procedure B, (E)-1-(hex-1-en-1-yl)pyrrolidine-2,5-dione (36.2 mg, 0.200 mmol) and 
dimethyl 2-methylenemalonate (57.7 mg, 0.400 mmol) were stirred for 60 minutes at room 
temperature. The crude oil was purified by column chromatography on Biotage (SNAP cartridge KP-
SIL 10 g, 95:5 to 4:6 Hexane/Ethyl acetate) affording cyclobutane 6ja (52.4 mg, 0.160 mmol, 81 % 
yield) as a colorless oil. 
Rf 0.34 (Hexane/Ethyl acetate 1/1). 
1H NMR (400 MHz, CDCl3) δ 4.89 (d, J = 9.9 Hz, 1H, N-C-H), 3.73 (s, 3H, CO2CH3), 3.70 (s, 3H, 
CO2CH3), 3.51 (m, 1H, CH2 cyclobutane), 2.96 (dd, J = 11.7, 9.2 Hz, 1H, CH2 cyclobutane), 2.75-2.58 
(m, 4H, CH2 succinimide), 1.72 (dd, J = 11.6, 9.1 Hz, 1H, CH2 cyclobutane), 1.52-1.37 (m, 2H, CH2 
butyl), 1.24 (m, 2H, CH2 butyl), 1.20 – 1.10 (m, 2H, CH2 butyl), 0.84 (t, J = 7.1 Hz, 3H, CH3 butyl). 
13C NMR (101 MHz, CDCl3) δ 177.2, 170.5, 168.6, 55.1, 54.0, 53.1, 53.0, 34.5, 33.5, 30.8, 28.7, 28.0, 
22.5, 14.0. 
IR 2957 (w), 2956 (w), 2856 (w), 1784 (w), 1736 (s), 1707 (s), 1436 (m), 1375 (m), 1262 (s), 1181 
(m), 1132 (s), 1041 (w). 
HRMS (ESI) calcd for C16H23NNaO6+ [M+Na]+ 348.1418; found 348.1411.  
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Dimethyl 2-(2,5-dioxopyrrolidin-1-yl)-3-phenethylcyclobutane-1,1-dicarboxylate (6ka) 
 
Using general procedure B, (E)-1-(4-phenylbut-1-en-1-yl)pyrrolidine-2,5-dione (45.9 mg, 0.200 
mmol) and dimethyl 2-methylenemalonate (57.7 mg, 0.400 mmol) were stirred for 60 minutes at room 
temperature. The crude oil was purified by column chromatography on Biotage (SNAP cartridge KP-
SIL 10 g, 95:5 to 4:6 Hexane/Ethyl acetate) affording cyclobutane 6ka (61.7 mg, 0.170 mmol, 83 % 
yield, 8:1 dr determined by integration of the peaks at 4.90 (maj), and 5.09 (min) in the crude 1H 
NMR) as a colorless oil. 
Rf 0.20 (Hexane/Ethyl acetate 1/1). 
1H NMR (400 MHz, CDCl3) on a 8(maj.):1(min.) mixture δ 7.27-7.22 (m, 18H, Ar maj + Ar min with 
chloroform peak), 7.19-7.05 (m, 26H, Ar maj + Ar min), 6.86-6.80 (m, 1H, Ar min), 5.09 (d, J = 10.5 
Hz, 1H, N-C-H min), 4.90 (d, J = 9.8 Hz, 8H, N-C-H maj), 3.72 (m, 30H, CO2CH3 maj + CO2CH3 
min), 3.68 (s, 24H, CO2CH3 maj), 3.59 (dtd, J = 16.8, 9.4, 7.3 Hz, 8H, CH2 cyclobutane maj), 3.46 (dd, 
J = 11.0, 4.3 Hz, 1H, CH2 cyclobutane min), 2.95 (dd, J = 11.4, 9.6 Hz, 8H, CH2 cyclobutane maj), 
2.67-2.45 (m, 52H, CH2 succinimide maj + CH2 succinimide min + CH2 chain maj), 2.95 (dd, J = 11.4, 
9.6 Hz, 1H, CH2 cyclobutane min), 2.13-1.99 (m, 2H, CH2 chain min), 1.85 (ddq, J = 17.0, 8.7, 6.8 Hz, 
18H CH2 chain maj + CH2 chain min), 1.73 (dd, J = 11.7, 9.1 Hz, 8H, CH2 cyclobutane maj), 1.54 (td, 
J = 12.9, 4.5 Hz, 1H, CH2 cyclobutane min). 
13C NMR (101 MHz, CDCl3) δ 177.0, 170.3, 168.4, 141.3, 128.3, 128.1, 125.9, 55.0, 54.0, 53.0, 52.9, 
36.2, 33.3, 33.1, 30.7, 27.8. Only major isomer. 
IR 2955 (w), 1784 (w), 1783 (w), 1739 (s), 1708 (s), 1673 (w), 1438 (w), 1437 (w), 1384 (m), 1374 
(m), 1315 (w), 1267 (s), 1197 (w), 1151 (m), 1150 (m).  
HRMS (ESI) calcd for C20H23NNaO6+ [M+Na]+ 396.1418; found 396.1427.  
Dimethyl 2-(1,3-dioxoisoindolin-2-yl)-3-phenylcyclobutane-1,1-dicarboxylate (6la) 
 
Using general procedure C, (E)-2-styrylisoindoline-1,3-dione (49.9 mg, 0.200 mmol) and dimethyl 2-
methylenemalonate (57.7 mg, 0.400 mmol) were stirred for 1 hour at room temperature after the end 
of the slow addition. The crude oil was purified by column chromatography on Biotage (SNAP 
cartridge KP-SIL 10 g, 95:5 to 4:6 Hexane/Ethyl acetate) affording cyclobutane 6la (70.6 mg, 0.179 
mmol, 90 % yield) as a colorless oil. 
Rf 0.28 (Hexane/Ethyl acetate 7/3). 
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1H NMR (400 MHz, CDCl3) δ 7.63 (dd, 2 H, J = 3.7, 2.1 Hz, Phth), 7.55 (dd, 2 H, J = 3.8, 2.1 Hz, 
Phth), 7.29-7.24 (m, 4 H, Ph), 7.23-7.19 (m, 1 H, Ph), 5.52 (dd, 1 H, J = 7.4, 0.4 Hz, N-C-H), 4.86-
4.96 (m, 1 H, H-C-Ph), 3.76 (s, 3 H, CO2CH3), 3.65 (s, 3 H, CO2CH3), 3.25 (ddd, 1 H, J = 7.7, 6.5, 0.4 
Hz, CH2), 2.21 (dd, 1 H, J = 7.8, 6.9 Hz, CH2). 
13C NMR (101 MHz, CDCl3) δ 158.8, 157.4, 157.2, 134.0, 128.8, 126.6, 124.1, 122.9, 122.5, 119.7, 
63.1, 61.4, 60.7, 60.7, 48.4, 42.9. 
IR 2199 (w), 1833 (m), 1790 (w), 1155 (s), 1127 (s), 940 (m), 890 (s), 842 (s). 
HRMS (ESI) calcd for C22H20NO6+ [M+H]+ 394.1285; found 394.1271. 
Dimethyl-3-(4-bromophenyl)-2-(1,3-dioxoisoindolin-2-yl)cyclobutane-1,1-dicarboxylate (6ma) 
 
Using general procedure C, (E)-2-(4-bromostyryl)isoindoline-1,3-dione (65.6 mg, 0.200 mmol) and 
dimethyl 2-methylenemalonate (115 mg, 0.800 mmol) were stirred for 3 hours at room temperature 
after the end of the slow addition. The crude oil was purified by column chromatography on Biotage 
(SNAP cartridge KP-SIL 10 g, 95:5 to 4:6 Hexane/Ethyl acetate) affording cyclobutane 6ma (47.0 
mg, 0.100 mmol, 50 % yield) as a colorless oil as well as of (E)-2-(4-bromostyryl)isoindoline-1,3-
dione (15.4 mg, 0.0469 mmol, 23%, 65% yield of 6ma b.r.s.m.). 
Rf 0.26 (Hexane/Ethyl acetate 7/3). 
1H NMR (400 MHz, CDCl3) δ 7.87-7.81 (m, 2H, Phth), 7.76-7.70 (m, 2H, Phth), 7.45-7.40 (m, 2H, 
Ar), 7.18-7.13 (m, 2H, Ar), 5.47 (dd, J = 10.9, 0.7 Hz, 1H, N-C-H), 4.88 (q, J = 10.1 Hz, 1H, Ar-C-H), 
3.78 (s, 3H, CO2CH3), 3.67 (s, 3H, CO2CH3), 3.26 (ddd, J = 11.6, 9.5, 0.8 Hz, 1H, CH2), 2.19 (dd, J = 
11.5, 10.0 Hz, 1H, CH2). 
13C NMR (101 MHz, CDCl3) δ 170.0, 168.3, 168.2, 139.5, 134.3, 131.8, 131.6, 128.6, 123.5, 121.1, 
55.9, 53.9, 53.20, 53.15, 38.0, 31.8. 
IR 2955 (w), 1782 (w), 1738 (s), 1721 (s), 1492 (w), 1437 (w), 1378 (s), 1267 (m), 1201 (m), 1049 
(w). 
HRMS (ESI) calcd for C2279BrH19NO6+ [M+H]+ 472.0390; found 472.0385. 
Dimethyl -3-(2-bromophenyl)-2-(1,3-dioxoisoindolin-2-yl)cyclobutane-1,1-dicarboxylate (6na) 
 
Using general procedure C, (E)-2-(2-bromostyryl)isoindoline-1,3-dione (65.6 mg, 0.200 mmol) and 
dimethyl 2-methylenemalonate (57.7 mg, 0.400 mmol) were stirred for 5 minutes at room temperature 
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after the end of the slow addition. The crude oil was purified by column chromatography on Biotage 
(SNAP cartridge KP-SIL 10 g, 95:5 to 4:6 Hexane/Ethyl acetate) affording cyclobutane 6na (87.4 mg, 
0.185 mmol, 93 % yield) as a colorless oil. 
Rf 0.32 (Hexane/Ethyl acetate 7/3). 
1H NMR (400 MHz, CDCl3) δ 7.88-7.79 (m, 2H, Phth), 7.77-7.66 (m, 2H, Phth), 7.50 (dd, J = 8.0, 1.2 
Hz, 1H, Ar), 7.38 (ddd, J = 7.9, 1.6, 0.6 Hz, 1H, Ar), 7.32-7.27 (m, 1H, Ar), 7.08 (dddd, J = 7.9, 7.3, 
1.7, 0.5 Hz, 1H, Ar), 5.74 (dd, J = 10.8, 0.8 Hz, 1H, N-C-H), 5.21-5.06 (m, 1H, Ar-C-H), 3.77 (s, 3H, 
CO2CH3), 3.69 (s, 3H, CO2CH3), 3.53 (ddd, J = 11.7, 9.6, 0.9 Hz, 1H, CH2), 2.06 (dd, J = 11.6, 9.7 Hz, 
1H, CH2). 
13C NMR (101 MHz, CDCl3) δ 170.3, 168.3, 168.2, 139.9, 134.4, 133.1, 131.7, 128.7, 127.9, 127.3, 
124.0, 123.6, 55.9, 53.30, 53.28, 51.5, 38.8, 31.9. 
IR 3062 (w), 2955 (w), 2848 (w), 1783 (w), 1738 (s), 1722 (s), 1471 (w), 1437 (m), 1379 (s), 1267 (s). 
HRMS (ESI) calcd for C2279BrH19NO6+ [M+H]+ 472.0390; found 472.0405. 
Dimethyl -2-(1,3-dioxoisoindolin-2-yl)-3-(4-(trifluoromethyl)phenyl)cyclobutane-1,1-
dicarboxylate (6oa) 
 
Using general procedure C, (E)-2-(4-(trifluoromethyl)styryl)isoindoline-1,3-dione (63.5 mg, 0.200 
mmol) and dimethyl 2-methylenemalonate (115 mg, 0.800 mmol) were stirred for 5 minutes at room 
temperature after the end of the slow addition. The crude oil was purified by column chromatography 
on Biotage (SNAP cartridge KP-SIL 10 g, 95:5 to 4:6 Hexane/Ethyl acetate) affording cyclobutane 
6oa (35.0 mg, 0.0760 mmol, 38 % yield, with a polymeric impurity) as a colorless oil as well as (E)-2-
(4-(trifluoromethyl)styryl)isoindoline-1,3-dione (10.3 mg, 0.0324 mmol, 16% yield, 45% yield of 6oa 
b.r.s.m.). 
Rf 0.25 (Hexane/Ethyl acetate 7/3). 
1H NMR (400 MHz, CDCl3) δ 7.85 (dd, J = 5.5, 3.1 Hz, 2H), 7.73 (dd, J = 5.5, 3.1 Hz, 2H, Phth), 
7.56 (d, J = 8.1 Hz, 2H, Ar), 7.39 (d, J = 8.0 Hz, 2H, Ar), 5.53 (d, J = 10.8 Hz, 1H, N-C-H), 4.99 (q, J 
= 10.1 Hz, 1H, Ar-C-H), 3.79 (s, 3H, OMe), 3.68 (s, 3H, OMe), 3.37 – 3.21 (m, 1H, CH2 
cyclobutane), 2.25 (dd, J = 11.6, 10.0 Hz, 1H, CH2 cyclobutane). 
13C NMR (101 MHz, CDCl3) δ 169.9, 168.1, 168.0, 144.5, 134.3, 131.5, 129.5 (q, J = 32.4 Hz), 127.0, 
125.7 (q, J = 3.3 Hz), 124.1 (q, J = 272.2 Hz), 123.5, 55.8, 53.6, 53.14, 53.08, 38.1, 31.5. 
IR 2957 (w), 1782 (w), 1737 (s), 1720 (s), 1620 (w), 1438 (w), 1378 (s), 1266 (s), 1200 (m), 1164 (s), 
1124 (s), 1049 (m). 
HRMS (ESI) calcd for C23H18F3NNaO6+ [M+Na]+ 484.0978; found 484.0996. 
Dimethyl-2-(1,3-dioxoisoindolin-2-yl)-3-(p-tolyl)cyclobutane-1,1-dicarboxylate (6pa) and 
dimethyl-3-(1,3-dioxoisoindolin-2-yl)-2-(p-tolyl)cyclobutane-1,1-dicarboxylate (6pa') 
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Using general procedure A, (E)-2-(4-methylstyryl)isoindoline-1,3-dione (52.7 mg, 0.200 mmol) and 
dimethyl 2-methylenemalonate (57.7 mg, 0.400 mmol) were stirred for 2h30 at room temperature. The 
crude oil was purified by column chromatography on Biotage (SNAP cartridge KP-SIL 10 g, 95:5 to 
4:6 Hexane/Ethyl acetate) affording cyclobutane 6pa (56.1 mg, 0.140 mmol, 69 % yield) as a colorless 
oil and cyclobutane 6pa' (22.5 mg, 0.0600 mmol, 28 % yield) as a colorless oil. The structure of 6pa 
was confirmed by 2D-NMR experiments. The structure of 6pa’ was assigned in analogy with the one 
of product 6qa’. 
 
6pa 
Rf 0.27 (Hexane/Ethyl acetate 7/3). 
1H NMR (400 MHz, CDCl3) δ 7.86-7.78 (m, 2H, Phth), 7.74-7.67 (m, 2H, Phth), 7.22-7.16 (m, 2H, 
Ar), 7.15-7.07 (m, 2H, Ar), 5.51 (dd, J = 10.9, 0.8 Hz, 1H, N-C-H), 4.88 (dd, J = 10.1, 10.1, Hz, 1H, 
Ar-C-H), 3.78 (s, 3H, CO2CH3), 3.67 (s, 3H, CO2CH3), 3.25 (ddd, J = 11.5, 9.5, 0.9 Hz, 1H, CH2 
cyclobutane), 2.30 (s, 3H, CH3), 2.20 (dd, J = 11.5, 10.1 Hz, 1H, CH2 cyclobutane). 
13C NMR (101 MHz, CDCl3) δ 170.2, 168.5, 168.2, 137.5, 136.9, 134.2, 131.7, 129.4, 126.8, 123.4, 
55.9, 54.1, 53.11, 53.08, 38.2, 32.1, 21.1. 
IR 3023 (w), 2955 (w), 1781 (w), 1736 (s), 1718 (s), 1518 (w), 1437 (w), 1378 (s), 1265 (s), 1199 (m), 
1048 (m), 881 (w). 
HRMS (ESI) calcd for C23H21NNaO6+ [M+Na]+ 430.1261; found 430.1257. 
 
6pa' 
Rf 0.32 (Hexane/Ethyl acetate 7/3). 
1H NMR (400 MHz, CDCl3) δ 7.85- 7.77 (m, 2H, Phth), 7.74- 7.66 (m, 2H, Phth), 7.32- 7.27 (m, 2H, 
Ar), 7.13-7.07 (m, 2H, Ar), 5.44 (dt, J = 10.2, 9.1 Hz, 1H, N-C-H), 5.18 (d, J = 10.3 Hz, 1H, Ar-C-H), 
3.87 (s, 3H, CO2CH3), 3.35 (s, 3H, CO2CH3), 3.29 (dd, J = 11.4, 9.2 Hz, 1H, CH2 cyclobutane), 3.00 
(ddd, J = 11.4, 9.0, 0.8 Hz, 1H, CH2 cyclobutane), 2.28 (s, 3H, CH3). 
13C NMR (101 MHz, CDCl3) δ 171.2, 169.5, 168.3, 137.1, 134.2, 133.0, 131.7, 129.0, 127.4, 123.3, 
54.4, 52.9, 52.3, 49.6, 42.2, 30.8, 21.1. 
IR 2954 (w), 2926 (w), 2863 (w), 1776 (w), 1734 (s), 1716 (s), 1437 (w), 1384 (m), 1277 (m), 1203 
(m), 1128 (m). 
HRMS (ESI) calcd for C23H22NO6+ [M+H]+ 408.1442; found 408.1451. 
Dimethyl-3-(1,3-dioxoisoindolin-2-yl)-2-(4-methoxyphenyl)cyclobutane-1,1-dicarboxylate (6qa') 
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Using general procedure A, (E)-2-(4-methoxystyryl)isoindoline-1,3-dione (55.9 mg, 0.200 mmol) and 
dimethyl 2-methylenemalonate (57.7 mg, 0.400 mmol) were stirred for 60 minutes at room 
temperature. The crude oil was purified by column chromatography on Biotage (SNAP cartridge KP-
SIL 10 g, 95:5 to 4:6 Hexane/Ethyl acetate) affording cyclobutane 6qa' (69.0 mg, 0.160 mmol, 81 % 
yield) as a colorless oil. 
Rf 0.15 (Hexane/Ethyl acetate 7/3). 
1H NMR (400 MHz, CDCl3) δ 7.84-7.78 (m, 2 H, Phth), 7.73-7.67 (m, 2 H, Phth), 7.36-7.30 (m, 2 H, 
Ar), 6.87-6.80 (m, 2 H, Ar), 5.46-5.38 (m, 1 H, Ar-C-H), 5.15 (d, 1 H, J = 10.3 Hz, N-C-H), 3.87 (s, 3 
H, CO2CH3), 3.76 (s, 3 H, Ar-OMe), 3.36 (s, 3 H, CO2CH3), 3.28 (dd, 1 H, J = 11.3, 9.2 Hz, CH2), 
2.99 (dd, 1 H, J = 11.3, 8.9 Hz, CH2). 
13C NMR (101 MHz, CDCl3) δ 171.3, 169.5, 168.3, 159.0, 134.2, 131.7, 128.8, 128.1, 123.4, 113.8, 
55.2, 54.4, 52.9, 52.4, 49.4, 42.4, 30.6. 
IR 3030 (w), 2955 (w), 1782 (w), 1739 (s), 1721 (s), 1378 (s), 1267 (s). 
HRMS (ESI) calcd for C23H22NO7+ [M+H]+ 424.1391; found 424.1387. 
Stereochemistry was assigned by 2D ROESY NMR experiment. 
 
Diethyl 2-(1,3-dioxoisoindolin-2-yl)-4-methylcyclobutane-1,1-dicarboxylate (6ab) 
 
Using general procedure B, 2-vinylisoindoline-1,3-dione (34.6 mg, 0.200 mmol) and diethyl 2-
ethylidenemalonate (74.5 mg, 0.400 mmol) were stirred for 18 h at room temperature. The crude oil 
was purified by column chromatography on Biotage (SNAP cartridge KP-SIL 10 g, 95:5 to 4:6 
Hexane/Ethyl acetate) affording cyclobutane 6ab (45.2 mg, 0.130 mmol, 63 % yield, 1.2:1 dr 
determined by integration of the peaks at 4.91 (maj), and 5.58 (min) in the crude 1H NMR) as a 
colorless oil. 
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Rf 0.25 (Hexane/Ethyl acetate 7/3). 
1H NMR (400 MHz, CDCl3) on a 1.6(maj.):1(min.) mixture δ 7.84-7.79 (m, 5.2 H, Phth maj + min), 
7.72-7.67 (m, 5.2H, Phth maj + min), 5.58 (ddd, J = 10.0, 8.3, 1.2 Hz, 1H, N-C-H min), 4.91 (dd, J = 
10.9, 8.7 Hz, 1.6H, N-C-H maj), 4.27-4.18 (m, 5.2H, CO2CH2 maj + min), 4.17- 3.91 (m, 5.2H, 
CO2CH2 maj + min), 3.65-3.54 (m, 1H, CH cyclobutane min), 3.27-3.12 (m, 2.6H, CH2 cyclobutane 
maj + min), 2.78 (ddq, J = 10.7, 8.1, 7.0 Hz, 1.6H, CH cyclobutane maj), 2.46 (dt, J = 10.8, 8.5 Hz, 
1.6H, CH2 cyclobutane maj), 1.98 (ddd, J = 11.7, 10.0, 5.4 Hz, 1H, CH2 cyclobutane min), 1.32 (d, J = 
7.0 Hz, 4.6H, CH3 maj), 1.28-1.21 (m, 7.8H, CO2CH2CH3 maj + min), 1.14 (d, J = 7.3 Hz, 3H, CH3 
min), 1.05 (t, J = 7.1 Hz, 4.6H, CO2CH2CH3 maj), 0.90 (t, J = 7.1 Hz, 3H, CO2CH2CH3 min). 
13C NMR (101 MHz, CDCl3) δ 170.2, 168.5, 168.4, 168.3, 168.1, 167.5, 134.1, 134.0, 132.0, 131.8, 
123.3, 123.2, 62.4, 62.0, 61.717, 61.6, 60.9, 47.5, 45.1, 33.8, 31.1, 29.6, 28.7, 16.5, 16.2, 14.2, 14.0, 
13.9, 13.6. 
IR 2929 (w), 2851 (w), 1780 (w), 1732 (s), 1713 (s), 1614 (w), 1468 (w), 1377 (s), 1256 (s), 1213 (m), 
1072 (m). 
HRMS (ESI) calcd for C19H21NNaO6+ [M+Na]+ 382.1261; found 382.1248.  
Dimethyl 2-(1,3-dioxoisoindolin-2-yl)-4-phenethylcyclobutane-1,1-dicarboxylate (6ad) 
 
Using general procedure B, 2-vinylisoindoline-1,3-dione (34.6 mg, 0.200 mmol) and dimethyl 2-(3-
phenylpropylidene)malonate (99.0 mg, 0.400 mmol) were stirred for 3h30 at room temperature. The 
crude oil was purified by column chromatography on Biotage (SNAP cartridge KP-SIL 10 g, 95:5 to 
4:6 Hexane/Ethyl acetate) affording cyclobutane 6ad (60.0 mg, 0.140 mmol, 71 % yield, 1.3:1 dr 
determined by integration of the peaks at 4.93 (maj), and 5.58 (min) in the crude 1H NMR) as a 
colorless oil. 
Rf 0.43 (Hexane/Ethyl acetate 7/3). 
1H NMR (400 MHz, CDCl3) on a 1.5(maj.):1(min.) mixture δ 7.87-7.79 (m, 5H, Phth maj + Phth min), 
7.75-7.67 (m, 5H, Phth maj + Phth min), 7.32-7.25 (m, 5H, Ar maj + Ar min with chloroform peak), 
7.19 (dd, J = 7.5, 4.9 Hz, 7.5H, Ar maj + Ar min), 5.58 (ddd, J = 10.2, 7.7, 1.1 Hz, 1H, N-C-H min), 
4.93 (dd, J = 11.1, 8.6 Hz, 1.5H, N-C-H maj), 3.78 (s, 4.5H, CO2CH3 maj), 3.74 (s, 3H, CO2CH3 min), 
3.60 (s, 4.5H, CO2CH3 maj), 3.54 (s, 3H, CO2CH3 min), 3.21 (q, J = 10.9 Hz, 1.5H, CH2 cyclobutane 
maj), 3.09 (ddd, J = 12.0, 10.1, 7.8 Hz, 1H, CH2 cyclobutane min), 2.75-2.54 (m, 7.5H, 1xCH2 
cyclobutane maj, 2xCH2 chain maj, 1xCH2 cyclobutane min, 2xCH2 chain min), 2.45 (dt, J = 10.6, 8.2 
Hz, 1.5H, CH2 cyclobutane maj), 2.24-2.06 (m, 2.5H, CH2 chain maj+ CH2 cyclobutane min), 2.01-
1.89 (m, 1.5H, CH2 chain maj), 1.89-1.80 (m, 1H, CH2 chain min), 1.76-1.63 (m, 1H, CH2 chain min). 
13C NMR (101 MHz, CDCl3) δ 170.5, 169.0, 168.9, 168.3, 168.0, 167.9, 141.7, 141.6, 134.2, 134.0, 
131.9, 131.7,128.45, 128.44, 128.40, 126.0, 125.9, 123.4, 123.2, 62.1, 61.5, 52.9, 52.8, 52.7, 52.2, 
47.7, 45.4, 38.6, 36.6, 33.5, 33.4, 33.1, 32.9, 28.5, 27.3.18 
                                                          
17 Two peaks under this signal as determined by HMBC. 
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IR 3028 (w), 2953 (w), 1780 (w), 1737 (s), 1715 (s), 1605 (w), 1496 (w), 1455 (w), 1436 (w), 1379 
(s), 1262 (m), 1199 (m), 1159 (w). 
HRMS (ESI) calcd for C24H23NNaO6+ [M+Na]+ 444.1418; found 444.1418. 
Dimethyl 2-cyclohexyl-4-(1,3-dioxoisoindolin-2-yl)cyclobutane-1,1-dicarboxylate (6ae) 
 
Using general procedure B, 2-vinylisoindoline-1,3-dione (34.6 mg, 0.200 mmol) and dimethyl 2-
(cyclohexylmethylene)malonate (91.0 mg, 0.400 mmol) were stirred for 18 h at room temperature. The 
crude oil was purified by column chromatography on Biotage (SNAP cartridge KP-SIL 10 g, 95:5 to 
4:6 Hexane/Ethyl acetate) affording cyclobutane 6ae (47.0 mg, 0.120 mmol, 59 % yield, 1.2:1 dr 
determined by integration of the peaks at 4.96 (min), and 5.38 (maj) in the crude 1H NMR) as a 
colorless oil. 
Rf 0.30 (Hexane/Ethyl acetate 7/3). 
1H NMR (400 MHz, CDCl3) on a 1.2(maj.):1(min.) mixture δ 7.87-7.79 (m, 4.4H, Phth maj + min), 
7.75-7.68 (m, 4.4H, Phth maj + min), 5.38 (ddd, J = 10.5, 5.1, 1.1 Hz, 1.2H, N-C-H maj), 4.93 (dd, J 
= 11.4, 8.0 Hz, 1H, N-C-H min), 3.79-3.76 (m, 6.6H, CO2CH3 maj + min), 3.59 (s, 3H, CO2CH3 min), 
3.56-3.48 (m, 4.8H, CO2CH3 maj + CH cyclobutane maj), 3.22 (td, J = 11.1, 9.9 Hz, 1H, CH2 
cyclobutane min), 2.72 (ddd, J = 12.4, 10.4, 5.1 Hz, 1.2H, CH2 cyclobutane maj), 2.45-2.27 (m, 3.2H, 
CH2 cyclobutane maj + min + CH cyclobutane min), 1.97-1.58 (m, 12.6H, CH cyclohexyl maj + min), 
1.40-0.98 (m, 8H, CH2 cyclohexyl maj + min), 0.96-0.73 (m, 3.6H, CH2 cyclohexyl maj). 
13C NMR (101 MHz, CDCl3) δ 171.0, 170.3, 170.2, 169.8, 168.5, 168.2, 134.3, 134.1, 132.0, 131.9, 
123.5, 123.4, 62.5, 61.1, 53.0, 52.8, 52.6, 52.2, 48.0, 46.1, 45.2, 44.0, 39.5, 39.4, 31.4, 31.3, 30.0, 
29.9, 29.6, 27.4, 26.7, 26.5, 26.1, 26.0, 25.9, 25.8. 
IR 2923 (w), 2851 (w), 1780 (w), 1732 (s), 1732 (s), 1714 (s), 1613 (w), 1436 (w), 1376 (s), 1265 (s), 
1204 (m), 1157 (w), 1061 (m). 
HRMS (ESI) calcd for C22H25NNaO6+ [M+Na]+ 422.1574; found 422.1590. 
Dibenzyl -2-(1,3-dioxoisoindolin-2-yl)-4-methylcyclobutane-1,1-dicarboxylate 6af 
 
Using general procedure B, 2-vinylisoindoline-1,3-dione (34.6 mg, 0.200 mmol) and dibenzyl 2-
ethylidenemalonate (124 mg, 0.400 mmol) were stirred for 18 h at room temperature. The crude oil 
was purified by column chromatography on Biotage (SNAP cartridge KP-SIL 10 g, 95:5 to 4:6 
                                                                                                                                                                                     
18 A peak is not resolved in the 128.45-128.40 massif. 
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Hexane/Ethyl acetate) affording cyclobutane 6af (60.5 mg, 0.125 mmol, 62 % yield, 3:1 dr determined 
by integration of the peaks at 3.64 (maj), and 2.49 (min) in the crude 1H NMR) as a colorless oil. 
Rf 0.22 (Hexane/Ethyl acetate 7/3). 
1H NMR (400 MHz, CDCl3) on a 2 (maj):1(min) diatereomeric mixture δ 7.77 – 7.68 (m, 6H, Phth), 
7.65 (ddd, J = 5.8, 3.2, 1.9 Hz, 6H, Phth), 7.34 – 7.27 (m, 15H, Ar), 7.19 – 7.06 (m, 6H, Ar), 7.06 – 
6.98 (m, 6H, Ar), 6.97 – 6.90 (m, 3H, Ar), 5.62 (ddd, J = 9.8, 8.4, 1.2 Hz, 2H, N-C-H maj), 5.27 – 
5.12 (m, 6H, CH2-Ar maj + min), 5.06 – 4.88 (m, 7H, N-C-H min, CH2-Ar maj + min), 3.64 (dddd, J 
= 10.1, 7.4, 5.2, 1.3 Hz, 2H, CH-Me cyclobutane maj), 3.28 – 3.13 (m, 3H, CH2 cyclobutane maj+ 
min), 2.86 – 2.74 (m, 1H, CH-Me cyclobutane min), 2.49 (dt, J = 10.7, 8.3 Hz, 1H, CH2 cyclobutane 
min), 1.99 (ddd, J = 11.6, 9.9, 5.3 Hz, 2H, CH2 cyclobutane maj), 1.32 (d, J = 7.0 Hz, 3H, Me 
cyclobutane min), 1.08 (d, J = 7.4 Hz, 6H, Me cyclobutane maj). 
13C NMR (101 MHz, CDCl3) δ 169.8, 168.3, 168.1, 168.1, 168.0, 167.2, 135.5, 135.2, 134.9, 134.8, 
133.9, 133.8, 131.8, 131.6, 128.5, 128.5, 128.4, 128.3, 128.3, 128.2, 128.2, 128.1, 128.1, 128.0, 128.0, 
126.0, 123.3, 123.2, 67.5, 67.4, 67.3, 67.0, 62.4, 62.1, 47.5, 45.1, 34.2, 31.3, 29.8, 28.8, 16.4, 16.2. 
IR 2470 (w), 2447 (w), 2386 (w), 1453 (w), 1418 (s), 1407 (s), 1199 (w), 1138 (s), 1045 (m), 1008 
(m), 956 (w). 
HRMS (ESI) calcd for C29H26NO6+ [M+H]+ 484.1755; found 484.1756. 
 
Dibenzyl-2-(1,3-dioxoisoindolin-2-yl)-4-(trifluoromethyl)cyclobutane-1,1-dicarboxylate (6ag) 
 
Using general procedure B, 2-vinylisoindoline-1,3-dione (34.6 mg, 0.200 mmol) and dibenzyl 2-
(2,2,2-trifluoroethylidene)malonate (146 mg, 0.400 mmol) were stirred for 18 h at room temperature. 
The crude oil was purified by column chromatography on Biotage (SNAP cartridge KP-SIL 10 g, 95:5 
to 4:6 Hexane/Ethyl acetate) affording cyclobutane 6ag (82.2 mg, 0.153 mmol, 76 % yield) as a 
colorless oil.  
Rf 0.18 (Hexane/Ethyl acetate 7/3). 
1H NMR (400 MHz, CDCl3) δ 7.75 – 7.64 (m, 4H, Phth), 7.33 – 7.26 (m, 5H, Ar), 7.11 – 7.05 (m, 1H, 
Ar), 7.02 – 6.97 (m, 2H, Ar), 6.92 – 6.88 (m, 2H, Ar), 5.87 – 5.67 (m, 1H, N-C-H), 5.30 – 5.01 (m, 
2H, CH2Ar), 5.00 – 4.77 (m, 2H, CH2Ar), 4.47 – 4.26 (m, 1H, CH2 cyclobutane), 3.23 (ddd, J = 12.8, 
10.8, 7.7 Hz, 1H, CH2 cyclobutane), 2.60 (ddd, J = 12.7, 10.4, 6.5 Hz, 1H, CH2 cyclobutane). 
13C NMR (101 MHz, CDCl3) δ 167.7, 166.2, 165.9, 134.6, 134.3, 134.1, 131.3, 128.5, 128.5, 128.5, 
128.3, 128.29, 128.26, 125.6 (q, J = 278 Hz), 123.6, 68.4, 68.3, 59.3, 45.3, 39.6 (q, J = 31.4 Hz), 22.6. 
19F NMR (376 MHz, CDCl3) δ -62.3. 
IR 3035 (w), 2963 (w), 1781 (m), 1741 (s), 1736 (s), 1456 (w), 1380 (s), 1276 (s), 1142 (s), 1088 (m). 
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HRMS (ESI) calcd for C29H22F3NNaO6+ [M+Na]+ 560.1291; found 560.1277. 
Stereochemistry was assigned by 2D ROESY NMR experiment. 
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5. Sequential synthesis of aminocyclobutanes 
Dimethyl 2-(1,3-dioxoisoindolin-2-yl)cyclobutane-1,1-dicarboxylate (6aa) 
 
Dimethyl malonate (7a) (1.32 mL, 11.6 mmol, 2 eq), diisopropylamine 2,2,2-trifluoroacetate (2.49 g, 
11.6 mmol, 2 eq), paraformaldehyde (0.695 mg, 23.1 mmol, 4 eq) and trifluoroacetic acid (89.0 µL, 
1.16 mmol, 0.2 eq) were added to tetrahydrofuran (20 mL). A condenser was added and the 
suspension was stirred at reflux for two hours. Paraformaldehyde (0.695 mg, 23.1 mmol, 4 eq) was 
added and the reflux was continued for 6 hours. The reaction was cooled to room temperature and the 
tetrahydrofuran was removed under reduced pressure (300 to 50 mbar at 45°C). The crude was 
dissolved in diethyl ether (25 mL) and filtered through cotton in a separatory funnel. The organic layer 
was washed twice with 1 M HCl (25 mL). The aqueous layers were combined and extracted with 
diethyl ether (25 mL). The organic layers were combined, dried over anhydrous Na2SO4, filtered and 
concentrated under reduced pressure to give dimethyl crude 2-methylenemalonate as colorless oil.  
The iron catalyst (289 mg, 0.289 mmol, 0.05 eq) was weighted in an oven-dry flask in a glovebox. The 
flask was closed with a silicon septum, taken out of the glovebox and put under positive pressure of 
nitrogen and dichloromethane (5 mL) was added. 2-vinylisoindoline-1,3-dione (4a) (1.00 g, 5.77 
mmol, 1 eq) was dissolved in dichloromethane (5 mL)and added to the yellow suspension. Finally, the 
crude dimethyl 2-methylenemalonate was dissolved in dichloromethane (5 mL) and added to the 
reaction in one portion. The reaction was stirred at room temperature for 16 h and then filtered over a 
basic alumina plug, eluting with ethyl acetate. The solvents were evaporated and the brown solid was 
purified by column chromatography on Biotage (SNAP cartridge KP-SIL 50 g, 95:5 to 4:6 
Hexane/Ethyl acetate) affording cyclobutane 6aa (1.55 g, 4.89 mmol, 85 % yield) as a colorless solid. 
1-(Tert-butyl) 1-methyl 2-(1,3-dioxoisoindolin-2-yl)cyclobutane-1,1-dicarboxylate (6ah) 
  
Tert-butyl methyl malonate (7d) (1.95 mL, 11.6 mmol, 2 eq), diisopropylamine 2,2,2-trifluoroacetate 
(2.49 g, 11.6 mmol, 2 eq), paraformaldehyde (0.695 mg, 23.1 mmol, 4 eq) and trifluoroacetic acid 
(89.0 µL, 1.16 mmol, 0.2 eq) were added to tetrahydrofuran (20 mL). A condenser was added and the 
suspension was stirred at reflux for two hours. Paraformaldehyde (0.695 mg, 23.1 mmol, 4 eq) was 
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added and the reflux was continued for 6 hours. The reaction mixture was cooled to room temperature 
and the tetrahydrofuran was removed under reduced pressure. The crude product was dissolved in 
diethyl ether (25 mL) and filtered through cotton in a separatory funnel. The organic layer was washed 
twice with 1 M HCl (25 mL). The aqueous layers were combined and extracted with diethyl ether (25 
mL). The organic layers were combined, dried over anhydrous Na2SO4, filtered and concentrated 
under reduced pressure to give crude methylenemalonate (2.9 g) as colorless oil.  
The iron catalyst (289 mg, 0.289 mmol, 0.05 eq) was weighted in an oven-dry flask in a glovebox. The 
flask was closed with a silicon septum, taken out of the glovebox and put under a positive pressure of 
nitrogen. Dichloromethane (5 mL) was added. The reaction was cooled to 0 °C and 2-vinylisoindoline-
1,3-dione (4a) (1.00 g, 5.77 mmol, 1 eq) was dissolved in dichloromethane (5 mL) and added to the 
yellow suspension dropwise. Finally, the crude methylenemalonate was dissolved in dichloromethane 
(5 mL) and added to the reaction mixture dropwise. The reaction mixture was stirred at 0 °C for 3h30 
and then filtered over a basic alumina plug, eluting with ethyl acetate. The solvents were evaporated 
and the brown solid was purified by column chromatography on Biotage (SNAP cartridge KP-SIL 50 
g, 95:5 to 4:6 Hexane/Ethyl acetate) affording cyclobutanes 6ah (1.97 g, 5.48 mmol, 95 % yield, 1.7:1 
dr determined by integration of the peaks at 2.45-2.33 (maj), and 2.31-2.21 (min) in the crude 1H 
NMR) as a colorless oil. 
Rf 0.22 (Hexane/Ethyl acetate 7/3). 
1H NMR (400 MHz, CDCl3) on a 1.5 (maj):1(min) diatereomeric mixture δ 7.95 – 7.78 (m, 5H, Phth), 
7.78 – 7.64 (m, 5H, Phth), 5.58 – 5.26 (m, 2.5H, N-C-H major + minor), 3.75 (s, 4.5H, OMe major), 
3.57 (s, 3H, OMe minor), 3.36 – 3.10 (m, 2.5H, CH2 cyclobutane major + minor), 3.08 – 2.83 (m, 
2.5H, CH2 cyclobutane major + minor), 2.45-2.33 (m, 1.5H, CH2 cyclobutane major), 2.31-2.21 (m, 1 
H, CH2 cyclobutane minor) 2.20-2.10 (m, 2.5 H, CH2 cyclobutane major + minor), 1.44 (s, 9H, tBu 
minor), 1.16 (s, 13.5H, tBu major). 
13C NMR (101 MHz, CDCl3) δ 171.2, 169.0, 169.0, 168.3, 168.2, 167.2, 134.3, 134.2, 132.1, 131.9, 
123.4, 123.4, 82.5, 82.2, 60.1, 59.5, 53.0, 52.8, 47.7, 47.6, 27.9, 27.5, 24.8, 24.3, 21.7, 21.3. 
IR 2979 (w), 1732 (s), 1717 (s), 1372 (s), 1266 (s), 1129 (m). 
HRMS (ESI) calcd for C19H22NO6+ [M+H]+ 360.1442; found 360.1437. 
Stereochemistry was assigned by 2D ROESY NMR experiment. 
 
Dibenzyl 2-(1,3-dioxoisoindolin-2-yl)cyclobutane-1,1-dicarboxylate (6ai) 
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Dibenzyl malonate (7c) (2.89 mL, 11.6 mmol, 2 eq), diisopropylamine 2,2,2-trifluoroacetate (2.49 g, 
11.6 mmol, 2 eq), paraformaldehyde (0.695 mg, 23.1 mmol, 4 eq) and trifluoroacetic acid (89.0 µL, 
1.16 mmol, 0.2 eq) were added to tetrahydrofuran (20 mL). A condenser was added and the 
suspension was stirred at reflux for two hours. Paraformaldehyde (0.695 mg, 23.1 mmol, 4 eq) was 
added and the reflux was continued for 6 hours. The reaction was cooled to room temperature and the 
tetrahydrofuran was removed under reduced pressure. The crude was retaken in diethyl ether (25 mL) 
and filtered through cotton in a separatory funnel. The organic layer was washed twice with 1M HCl 
(25 mL). The aqueous layers were combined and extracted with diethyl ether (25 mL). The organic 
layers were combined, dried over anhydrous Na2SO4, filtered and concentrated under reduced pressure 
to give dibenzyl 2-methylenemalonate crude as colorless oil.   
The iron catalyst (289 mg, 0.289 mmol, 0.05 eq) was weighted in an oven-dry flask in a glovebox. The 
flask was closed with a silicon septum, taken out of the glovebox and put under a positive pressure of 
nitrogen. Dichloromethane (5 mL) was added. The reaction was cooled to 0 °C and 2-vinylisoindoline-
1,3-dione (4a) (1.00 g, 5.77 mmol, 1 eq) was dissolved in dichloromethane (5 mL) and added to the 
yellow suspension dropwise. Finally, the crude dibenzyl 2-methylenemalonate was dissolved in 
dichloromethane (5 mL) and added to the reaction mixture dropwise. The reaction mixture was stirred 
at room temperature for 2 hours and then filtered over a basic alumina plug, eluting with ethyl acetate. 
The solvents were evaporated and the brown solid was purified by column chromatography on Biotage 
(SNAP cartridge KP-SIL 50 g, 95:5 to 4:6 Hexane/Ethyl acetate) affording cyclobutane 6ai (2.60 g, 
5.54 mmol, 96 % yield) as a colorless oil that solidify upon storage at 4°C. 
Rf 0.45 (Hexane/Ethyl acetate 6/4). 
Mp 132.1-133.8 °C. 
1H NMR (400 MHz, CDCl3) δ 7.74 – 7.68 (m, 2H, Phth), 7.68 – 7.61 (m, 2H, Phth), 7.34 – 7.26 (m, 
5H, Ar), 7.14 – 7.07 (m, 1H, Ar), 7.06 – 7.00 (m, 2H, Ar), 6.97 – 6.91 (m, 2H, Ar), 5.50 (td, J = 9.5, 
0.9 Hz, 1H, N-C-H), 5.17 (q, J = 12.3 Hz, 2H, CH2Bn), 5.02 – 4.87 (m, 2H, CH2Bn), 3.34 – 3.16 (m, 
1H, CH2 cyclobutane), 3.02 (dddd, J = 11.7, 10.5, 3.8, 1.0 Hz, 1H, CH2 cyclobutane), 2.32 (dtd, J = 
11.2, 9.1, 3.7 Hz, 1H, CH2 cyclobutane), 2.18 (dt, J = 11.6, 8.8 Hz, 1H, CH2 cyclobutane). 
13C NMR (101 MHz, CDCl3) δ 169.7, 168.1, 167.9, 135.3, 134.7, 134.0, 131.6, 128.5, 128.3, 128.2, 
128.1, 128.1, 126.0, 123.3, 67.7, 67.5, 59.2, 47.6, 24.4, 21.8. 
IR IR 3034 (w), 2360 (w), 2339 (w), 1780 (w), 1738 (s), 1721 (s), 1379 (s), 1378 (s), 1261 (m), 1260 
(m). 
HRMS (ESI) calcd for C28H24NO6+ [M+H]+ 470.1598; found 470.1607. 
Dimethyl 2-(1,3-dioxoisoindolin-2-yl)-3-methylcyclobutane-1,1-dicarboxylate (6fa) 
 
Dimethyl malonate (7a) (1.22 mL, 10.7 mmol, 2 eq), diisopropylamine 2,2,2-trifluoroacetate (2.30 g, 
10.7 mmol, 2 eq), paraformaldehyde (0.640 mg, 21.4 mmol, 4 eq) and trifluoroacetic acid (82.0 µl, 
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1.07 mmol, 0.2 eq) were added to tetrahydrofuran (20 mL). A condenser was added and the 
suspension was stirred at reflux for two hours. Paraformaldehyde (0.640 mg, 21.4 mmol) was added 
and the reflux was continued for 6 hours. The reaction was cooled to room temperature and the 
tetrahydrofuran was removed under reduced pressure. The crude was dissolved in diethyl ether (25 
mL) and filtered through cotton in a separatory funnel. The organic layer was washed twice with 1M 
HCl (25 mL). The aqueous layers were combined and extracted with diethyl ether (25 mL). The 
organic layers were combined, dried over anhydrous Na2SO4, filtered and concentrated under reduced 
pressure to give dimethyl 2-methylenemalonate crude as colorless oil.  
The iron catalyst (267 mg, 0.267 mmol, 0.05 eq) was weighted in an oven-dry flask in a glovebox. The 
flask was closed with a silicon septum, taken out of the glovebox and put under a positive pressure of 
nitrogen. Dichloromethane (5 mL) was added. The reaction was cooled to 0 °C and (E)-2-(prop-1-en-
1-yl)isoindoline-1,3-dione (4f) (1.00 g, 5.34 mmol, 1 eq) was dissolved in dichloromethane (5 mL) 
and added to the yellow suspension dropwise. Finally, the crude dimethyl 2-methylenemalonate was 
dissolved in dichloromethane (5 mL) and added to the reaction mixture dropwise. The reaction 
mixture was stirred at room temperature for 4 hours and then filtered over a basic alumina plug, 
eluting with ethyl acetate. The solvents were evaporated and the brown solid was purified by column 
chromatography on Biotage (SNAP cartridge KP-SIL 50 g, 95:5 to 4:6 Hexane/Ethyl acetate) 
affording cyclobutane 6fa (1.53 g, 4.62 mmol, 86 % yield) as a colorless solid. 
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6. Synthesis of labeled reagents. 
2-((Trimethylsilyl)ethynyl)isoindoline-1,3-dione (27) 
 
Following a reported procedure,19 copper acetate (0.617 g, 3.40 mmol, 0.2 eq), phthalimide (25) (12.5 
g, 85.0 mmol, 5 eq), sodium carbonate (3.60 g, 34.0 mmol, 2 eq) and 4Å molecular sieves (10.0 g) 
were combined in a 1 L three neck round bottom flask equipped with a large magnetic stirring bar. A 
solution of pyridine (2.75 mL, 34.0 mmol, 2 eq) in dry toluene (150 mL) was added to the reaction 
flask. The mixture was stirred vigorously and the reaction atmosphere was flushed using oxygen from 
a balloon. Finally a large balloon of oxygen was connected to the flask and the reaction was stirred in 
a preheated oil bath at 70 °C. After two hours of stirring at 70 °C, a solution of ethynyltrimethylsilane 
(26) (2.42 mL, 17.0 mmol, 1 eq) in dry toluene (20 mL) was added to the flask in two hours using 
syringe pump. After the end of addition, the reaction was stirred for 15 additional hours at 70 °C. The 
reaction mixture was filtered warm through a glass frit and the filtrate was concentrated under reduced 
pressure. The residue was suspended in diethyl ether (50 mL) and washed with sat. NH4Cl (50 mL) 
The layers were separated and the organic layer was dried over anhydrous Na2SO4, filtered and 
concentrated to dryness to give an off-white solid. Purification of the crude solid by column 
chromatography (SiO2, hexane/ethyl acetate, 95:5 to 80:20,) afforded 2-
((trimethylsilyl)ethynyl)isoindoline-1,3-dione (27) (2.80 g, 11.5 mmol, 68%) as a white fluffy solid. 
1H NMR (400 MHz, CDCl3) δ 7.93 (dd, J = 5.5, 3.1 Hz, 2H), 7.81 (dd, J = 5.5, 3.1 Hz, 2H), 0.29 (s, 
9H). 
Data match literature report.19 
(Z)-2-(Vinyl-2-d)isoindoline-1,3-dione (4r) 
 
2-((Trimethylsilyl)ethynyl)isoindoline-1,3-dione (27) (300 mg, 1.23 mmol, 1 eq) was dissolved in 
thetrahydrofuran (1 mL), then D2O (0.5 mL) was added and the reaction was stirred at 0 °C for 5 
minutes. TBAF (1 M in thetrahydrofuran, 1.48 mL, 1.48 mmol, 1.2 eq) was added in another flask 
containing tetrahydrofuran (2 mL) and D2O (0.5 mL). The TBAF solution was then added dropwise to 
the ynimide solution. After 10 minutes at 0 °C (some ice has formed during the process), ethyl acetate 
(10 mL) was added, followed by sat. NH4Cl (10 mL). The layers were stirred vigorously and the 
                                                          
19 Alford, J. S.; Davies H. M. L. Org. Lett., 2012, 14 , 6020 
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organic layer was separated, dried over anhydrous Na2SO4, filtered and concentrated to dryness to give 
an orange solid. The crude product was purified by column chromatography (SiO2, 7:3, hexane/ethyl 
acetate) affording deuterated ynamide (138 mg, 0.802 mmol, 65 %, 88 % deuterium incorporation 
determined by the integrations of the peak at 7.88-7.79 and 3.34) as colorless solid. 
1H NMR (400 MHz, CDCl3) δ 8.02 – 7.88 (m, 16H), 7.88 – 7.79 (m, 16H), 3.34 (s, 1H). 
13C NMR (126 MHz, CDCl3) δ 165.1, 135.4, 131.0, 124.5, 67.9.20 
Lindlar catalyst (25 mg, 0.012 mmol, 0.05 eq) and quinoline (5.0, 0.039 mmol, 0.16 eq) were added in 
dichloromethane (1.0 mL) in a flask under nitrogen atmosphere. The mixture was stirred for 5 minutes 
and 2-(ethynyl-d)isoindoline-1,3-dione (40 mg, 0.23 mmol, 1 eq) was added as a solution in 
dichloromethane (0.5 mL). The reaction atmosphere was flushed with hydrogen and a hydrogen 
balloon was connected to the flask. The reaction was stirred for one hour at room temperature and then 
filtered on a celite pad, eluting with dichloromethane. The solvent was removed under reduced 
pressure and the crude product was purified by column chromatography on Biotage (SNAP cartridge 
KP-SIL 10 g, 95:5 to 4:6 Hexane/Ethyl acetate) affording (Z)-2-(vinyl-2-d)isoindoline-1,3-dione (4r) 
(32.5 mg, 0.190 mmol, 80 % yield with 20% of the saturated compound, 3.3:1 Z/E ratio and 75% 
deuterium incorporation) as a colorless solid. 
Rf 0.60 (Hexane/Ethyl acetate 7/3). 
1H NMR (400 MHz, CDCl3) δ 7.99 – 7.63 (m, 4.7H, Phth), 6.97 – 6.77 (m, 1H, H1 no-D + Z + E), 
6.09 (dd, J = 16.4, 5.2 Hz, 0.43H, H2 no-D + E), 5.05 (dd, J = 9.9, 5.4 Hz, 0.83H, H3 no-D + Z), 3.81 – 
3.68 (m, 0.35H, CH2 saturated), 1.35 – 1.19 (m, 0.50H, CH3 saturated). 
13C NMR (101 MHz, CDCl3) δ 166.7, 134.6, 131.8, 124.0, 124.0, 123.8, 104.7, 104.4, 104.2. 
IR 1776 (w), 1724 (s), 1617 (w), 1468 (w), 1383 (s). 
HRMS (ESI) calcd for C10H7[2H]NO2+ [M+H]+ 175.0611; found 175.0620. 
Determination of deuterium incorporation and Z/E ratio: 
 
 
Dimethyl 2-(1,3-dioxoisoindolin-2-yl)cyclobutane-1,1-dicarboxylate-3-d (6ra) 
                                                          
20 The deuterated carbon was not resolved. 
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In the glovebox, Iron trichloride supported on alumina (1.00 mmol/g, 11.0 mg, 0.011 mmol, 0.1 eq) 
was added to a microwave vial. The vial was sealed with a Teflon septum and taken out of the 
glovebox. Dry dichloromethane (200 µL) was added and the yellow suspension was cooled to 0 °C. 
Dimethyl 2-methylenemalonate (5a) (16.4 mg, 0.114 mmol, 2 eq) and (Z)-2-(vinyl-2-D)isoindoline-
1,3-dione (4r) (12.4 mg, 0.0570 mmol, 1 eq) were dissolved in dry dichloromethane (800 µL) . The 
solution was then added dropwise to the iron trichloride solution. The reaction was stirred at 0 °C for 1 
hour. The reaction mixture was filtered over a pad of alumina, eluted with ethyl acetate and 
concentrated under vacuum. The crude product was purified by column chromatography on Biotage 
(SNAP cartridge KP-SIL 10 g, 95:5 to 4:6 Hexane/Ethyl acetate) affording dimethyl (2R,3R)-2-(1,3-
dioxoisoindolin-2-yl)cyclobutane-1,1-dicarboxylate-3-d (6ra) (17.0 mg, 0.0530 mmol, 94 % yield, 
2.7:1.0 diastereomeric ratio and 75% deuterium incorporation determined by the same method than 
previously, integrating the peaks at 5.51 – 5.39 (no-D + cis + trans) 3.32 – 3.15 (trans + no-D) and 
2.36 – 2.23 (cis + no-D)) as a colorless solid. The relative stereochemistry was determined by ROESY 
experiments. 
Rf 0.45 (Hexane/Ethyl acetate 1/1). 
1H NMR (500 MHz, Chloroform-d) δ 7.91 – 7.77 (m, 2H, Phth), 7.75 – 7.64 (m, 2H, Phth), 5.51 – 
5.39 (m, 1H, H1 cis + trans + no-D), 3.75 (s, 3H, OMe), 3.60 (s, 3H, OMe), 3.32 – 3.15 (m, 0.46H, H2 
trans + no-D), 3.05 – 2.85 (m, 1H, CH2 cyclobutane), 2.36 – 2.23 (m, 0.83H, H3 cis + no-D), 2.23 – 
2.09 (m, 1H, CH2 cyclobutane). 
13C NMR (101 MHz, CDCl3) δ 170.4, 168.5, 168.1, 134.1, 131.7, 123.3, 58.74, 58.69, 53.0, 52.8, 
47.6, 47.50, 47.48, 24.4, 24.3, 21.7, 21.6, 21.4, 21.2. 
IR 2959 (w), 2923 (w), 2852 (w), 1779 (w), 1738 (s), 1715 (s), 1436 (w), 1377 (s), 1263 (s). 
HRMS (ESI) calcd for C16H15[2H]NO6+ [M+H]+ 319.1034; found 319.1025. 
Determination of deuterium incorporation and cis/trans ratio: 
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7. Formal [4+2] 
Tert-butyldimethyl((1-phenylvinyl)oxy)silane (28) 
 
Acetophenone (580 mg, 4.82 mmol, 1 eq) in anhydrous THF (5 mL) is added in an oven-dried flask 
sealed with a septum and under N2 atmosphere. The solution is cooled down to -78 °C and a 2 M 
solution of NaHMDS (2.94 mL, 5.88 mmol, 1.22 eq) is added dropwise. The cold bath is removed and 
the pale yellow solution is stirred for 1 hour at room temperature. The reaction is cooled again at -78 
°C and tert-butylchlorodimethylsilane (871 mg, 5.78 mmol, 1.2 eq) is added dropwise. The reaction is 
stirred at room temperature for 5 hours after what the solvent is directly removed under reduced 
pressure. The resulting orange oil is purified by column chromatography on triethylamine-deactivated 
silica (100 % Hexane). Tert-butyldimethyl((1-phenylvinyl)oxy)silane (28) (960 mg, 4.10 mmol, 85% 
yield) is obtained as a colorless oil which can be re-purified by short path distillation in case of 
degradation with time. 
1H NMR (400 MHz, CDCl3) δ 7.65-7.60 (m, 2 H, Ar), 7.39-7.29 (m, 3 H, Ar), 4.89 (d, 1 H, J = 1.7 
Hz, C=CH2), 4.42 (d, 1 H, J = 1.7 Hz, C=CH2), 1.00 (s, 9 H, Si(CH3)2C(CH3)3), 0.21 (s, 6 H, 
Si(CH3)2C(CH3)3).  
13C NMR (101 MHz, CDCl3) δ 156.0, 137.8, 128.2, 128.1, 125.3, 90.9, 25.9, 18.4, -4.6. 
Data match literature report.21 
Dimethyl -2-((tert-butyldimethylsilyl)oxy)-4-(1,3-dioxoisoindolin-2-yl)-2-phenylcyclohexane-1,1-
dicarboxylate (10)  
                                                          
21 J.-F. Zhao, B.-H. Tan, T.-P. Loh Chem. Sci. 2011, 2, 349. 
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4Å MS pellets (ca 20 mg) were added in an oven dried 5 mL round bottom flask. The flask was closed 
with a silicon septum and three cycles of vacuum/N2 were performed. Dimethyl 2-(1,3-
dioxoisoindolin-2-yl)cyclobutane-1,1-dicarboxylate (6aa) (63.5 mg, 0.200 mmol, 1 eq) and tert-
butyldimethyl((1-phenylvinyl)oxy)silane (28) (70.4 mg, 0.300 mmol, 1.5 eq) were dissolved in 
dichloromethane (2 mL ) and added to the reaction flask. The solution was cooled to -40 °C using an 
acetonitrile/N2 bath. A solution of tin tetrachloride (0.43 mol/L, 93.0 µL, 0.0400 mmol, 0.2 eq,) was 
added dropwise and the reaction was stirred for 1 hour at -40 °C. The reaction was then quenched by 
adding triethylamine (0.1 mL) and the solvent was removed under reduced pressure. The reaction was 
purified by column chromatography on Biotage (SNAP cartridge KP-SIL 25 g, 95:5 to 4:6 
Hexane/Ethyl acetate) affording aminocyclohexane 10 (105 mg, 5.48 mmol, 95 % yield) as a colorless 
solid. 
Rf 0.61 (Hexane/Ethyl acetate 6/4). 
Mp 188.8-190.0 °C. 
1H NMR (400 MHz, CDCl3) δ 7.83 (dd, J = 5.5, 3.0 Hz, 2H, Phth), 7.72 (dd, J = 5.4, 3.1 Hz, 2H, 
Phth), 7.44 – 7.38 (m, 2H, Ar), 7.26 – 7.21 (m, 3H, Ar), 4.86 (tt, J = 12.5, 4.7 Hz, 1H, N-C-H), 3.96 
(dd, J = 13.6, 12.6 Hz, 1H, CH2 cyclohexane), 3.66 (s, 3H, OMe), 3.64 (s, 3H, OMe), 2.91 (td, J = 
14.2, 3.7 Hz, 1H, CH2 cyclohexane), 2.31 (dt, J = 13.8, 3.5 Hz, 1H, CH2 cyclohexane), 2.23 – 2.01 (m, 
2H, CH2 cyclohexane), 1.88 – 1.74 (m, 1H, CH2 cyclohexane), 1.06 (s, 9H, Si-tBu), 0.14 (s, 3H, Si-
Me), -0.55 (s, 3H, Si-Me). 
13C NMR (101 MHz, CDCl3) δ 170.1, 169.9, 168.4, 143.0, 134.1, 132.1, 128.8, 127.8, 126.5, 123.3, 
79.7, 64.6, 52.3, 52.0, 46.6, 36.7, 29.4, 26.4, 25.3, 19.3, -1.3, -2.5. 
IR 2953 (w), 2890 (w), 2856 (w), 2361 (w), 2339 (w), 1735 (s), 1714 (s), 1373 (m), 1274 (m), 1245 
(m), 1039 (m), 1038 (m). 
HRMS (ESI) calcd for C30H37NNaO7Si+ [M+Na]+ 574.2231; found 574.2228. 
 
Dimethyl-4-amino-2-((tert-butyldimethylsilyl)oxy)-2-phenylcyclohexane-1,1-dicarboxylate (10’)  
 
Dimethyl 2-((tert-butyldimethylsilyl)oxy)-4-(1,3-dioxoisoindolin-2-yl)-2-phenylcyclohexane-1,1-
dicarboxylate (10a) (50 mg, 0.091 mmol, 1 eq) in isopropanol ( 1.0 mL) and toluene (0.5 mL) was 
added in an oven dried 5 mL round bottom flask followed by diaminoethane (27.2 mg, 0.45 mmol, 5 
eq). The vial was sealed and the solution was heated to 80 °C for 16 hour. The solvent was removed 
under reduced pressure and the crude was purified by column chromatography (SiO2, 9:1 
DCM/Methanol) affording dimethyl 4-amino-2-((tert-butyldimethylsilyl)oxy)-2-phenylcyclohexane-
1,1-dicarboxylate 10’ (33 mg, 0.079 mmol, 87 % yield, > 95% pure) as a colorless oil. 
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Rf 0.20 (DCM/Methanol). 
1H NMR (400 MHz, CDCl3) δ 7.44 – 7.38 (m, 2H, Ar), 7.25 – 7.22 (m, 3H, Ar), 3.60 (s, 3H, 
COOMe), 3.55 (s, 3H, COOMe), 3.23 (ddt, J = 11.7, 8.7, 4.2 Hz, 1H, N-CH), 2.81 – 2.61 (m, 2H, 
CH2), 2.24 – 2.06 (m, 2H, CH2), 1.99 – 1.85 (m, 1H, CH2), 1.43 – 1.22 (br, 7H, NH2 and H2O),22 1.02 
– 0.84 (m, 10H, Si-tBu and CH2), 0.05 (s, 3H, SiMe), -0.60 (s, 3H, SiMe). 
13C NMR (101 MHz, CDCl3) δ 170.2, 169.9, 143.2, 128.6, 127.4, 126.1, 79.5, 64.4, 51.8, 51.5, 46.0, 
44.6, 32.5, 29.4, 26.0, 18.9, -1.4, -3.1. 
IR 3056 (w), 2953 (w), 2888 (w), 2860 (w), 1732 (m), 1447 (w), 1436 (w), 1266 (s), 1155 (w), 1136 
(w), 1044 (m), 1031 (m). 
HRMS (ESI) calcd for C22H36NO5Si+ [M+H]+ 422.2357; found 422.2353. 
  
                                                          
22 NH2 peak over-integrated due to water in CDCl3 
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8. Synthesis of dipeptide 11 
Ethyl (-2-(1,3-dioxoisoindolin-2-yl)cyclobutane-1-carbonyl)glycinate (11) 
 
Under nitrogen, dibenzyl 2-(1,3-dioxoisoindolin-2-yl)cyclobutane-1,1-dicarboxylate (6ai) (1.00 g, 
2.13 mmol, 1 eq) was dissolved in technical ethanol (15 mL). Palladium on charcoal 5% (0.453 g, 
0.213 mmol, 0.1 eq) was added and the reaction atmosphere was purged with hydrogen. The reaction 
was stirred at room temperature for 5 hours. Celite (ca 5 g) was added to the reaction and the 
suspension was filtered through a pad of celite. The cake was rinsed abundantly with hot ethanol. The 
solvents were removed on a rotary evaporator and the solid crude diacid was directly used for the next 
step. 
In a glovebox, copper (I) oxide (30.5 mg, 0.213 mmol, 0.1 eq) was added in a vial which was closed 
with a silicon septum and removed from the glovebox. The crude diacid was quickly added as a solid, 
the vial was sealed and three cycles of vacuum/N2 were performed. Dry acetonitrile (2 mL) was added 
and the reaction was stirred in an oil bath at 80 °C for 3 hours when no more starting material was 
detected by NMR. The reaction was cooled to room temperature and poured into a separatory funnel. 1 
M HCl (15 mL) and ethyl acetate (15 mL) were added. The layers were separated and the aqueous 
layer was extracted with ethyl acetate (15 mL). The organic layers were combined, dried over 
anhydrous Na2SO4, filtered and concentrated to dryness. The crude was purified on column 
chromatography (SiO2, DCM/MeOH/AcOH, 98:2:0.01 to 90:10:0.01) affording 2-(1,3-
dioxoisoindolin-2-yl)cyclobutanecarboxylic acid (447 mg, 1.83 mmol, 86% on two steps, 5:1 dr 
determined by integration of the peaks at 5.02 (maj), and 4.91 (min) in the crude 1H NMR) as a 
colorless oil. 
Mp 103.8-105.9 °C. 
Rf 0.23 (DCM/MeOH/AcOH 90:10:0.01). 
1H NMR (400 MHz, CDCl3) on a 5 (maj):1(min) diatereomeric mixture δ 7.81 (m, 12H, Phth), 7.71 
(m, 12H, Phth), 5.02 (q, J = 9.1 Hz, 5H, N-C-H, major), 4.91 (q, J = 9.2 Hz, 1H, N-C-H, minor), 4.12 
(q, J = 9.4 Hz, 1H, CH2 cyclobutane, minor), 3.65 – 3.54 (m, 5H, CH2 cyclobutane, major), 3.21 – 
3.08 (m, 5H, CH2 cyclobutane, major), 2.79 (m, 1H, CH2 cyclobutane, minor), 2.64 (m, 5H, CH2 
cyclobutane, major), 2.42 (m, 5H, CH2 cyclobutane, major), 2.31 – 1.97 (m, 8H, CH2 cyclobutane, 
major + minor). 
13C NMR (101 MHz, CDCl3) δ 178.2, 177.2, 168.5, 168.2, 134.1, 134.0, 131.8, 131.7, 123.34, 123.29, 
46.3, 45.5, 43.2, 42.5, 24.6, 24.0, 19.7, 18.9. 
2-(1,3-Dioxoisoindolin-2-yl)cyclobutanecarboxylic acid (200 mg, 0.816 mmol, 1 eq), N-ethyl-N-
isopropylpropan-2-amine (316 mg, 2.45 mmol, 3 eq) and HOBT (187 mg, 1.22 mmol, 1.5 eq), were 
added in a flask, dichloromethane (2 mL) was added and the reaction was cooled to 0 °C. Then, 3-
(((ethylimino)methylene)amino)-N,N-dimethylpropan-1-amine hydrochloride (235 mg, 1.22 mmol, 
1.5 eq) and finally ethyl 2-aminoacetate hydrochloride (114 mg, 0.816 mmol, 1 eq) were added and 
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the reaction was warmed to room temperature and stirred for 24 hours. The reaction was then 
concentrated to dryness and purified on column chromatography (SiO2, DCM/MeOH/AcOH, 
98:2:0.01 to 90:10:0.01) affording ethyl 2-(2-(1,3-dioxoisoindolin-2-
yl)cyclobutanecarboxamido)acetate (11) (244 mg, 0.740 mmol, 91%, 5:1 dr determined by integration 
of the peaks at 3.33-3.14 (maj), and 4.26-4.13 (min) in the isolated product 1H NMR) as a colorless oil. 
Rf 0.35 (DCM/MeOH/AcOH 9/1/0.01). 
1H NMR (400 MHz, CDCl3) on a 5 (maj):1(min) diatereomeric mixture δ 7.88 – 7.75 (m, 12H, Phth 
major+ minor), 7.74 – 7.62 (m, 12H, Phth major+ minor), 6.24 (s, 1H, NH minor), 5.97 (s, 5H, NH, 
major), 5.01 – 4.83 (m, 6H, N-C-H major+ minor), 4.26 – 4.13 (m, 2H, CH2 O-CH2 minor), 4.11 – 
3.96 (m, 13H, 2H O-CH2 major + 2H CH2 glycine minor + 1H CH2 cyclobutane minor), 3.95 – 3.79 
(m, 10H, CH2 glycine major), 3.66 – 3.49 (m, 5H, CH2 cyclobutane major), 3.33 – 3.14 (m, 5H, CH2 
cyclobutane major), 2.80 – 2.57 (m, 6H, CH2 cyclobutane major + minor), 2.57 – 2.44 (m, 5H, CH2 
cyclobutane major), 2.30 – 2.02 (m, 8H, 1H CH2 cyclobutane major + 2H CH2 cyclobutane minor), 
1.26 (t, J = 7.2 Hz, 3H, CH3 minor), 1.19 (t, J = 7.1 Hz, 15H, CH3 major). 
13C NMR (101 MHz, CDCl3) δ 172.2, 171.3, 169.8, 169.6, 168.6, 168.3, 134.1, 133.7, 132.0, 131.7, 
123.2, 123.1, 61.4, 61.2, 46.9, 46.8, 44.5, 44.0, 41.3, 41.3, 24.3, 24.0, 20.6, 19.0, 14.03, 13.98. 
IR 3595 (w), 3377 (w), 2987 (w), 1777 (w), 1748 (w), 1713 (s), 1662 (w), 1538 (w), 1381 (s), 1201 
(m), 1027 (w). 
HRMS (ESI) calcd for C17H19N2O5+ [M+H]+ 331.1288; found 331.1290. 
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9. Spectra of new compounds 
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